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Abstract 
 
Susan M. Deupree:  Bioanalytical Methods for Investigating Bacterial Adhesion and the 
Antibacterial Action of Nitric Oxide 
 
(Under the direction of Professor Mark Schoenfisch.) 
 
 
Infection is a continuing problem in both hospital and community settings, further 
compounded by swift adaptation and rising emergence of more virulent and antibacterial-
resistant pathogens.  The complex mechanisms underlying the process of infection must be 
understood in order to develop preventative technologies.  Simultaneously, effective 
solutions must be devised to counter infections as they arise.  My dissertation research has 
contributed to both aspects by working to understand the process of adhesion as well as the 
development of novel therapeutic strategies. 
To investigate bacterial adhesion at a fundamental level, a quantitative method was 
developed for measuring the shear force required to detach individual adhered bacteria using 
atomic force microscopy (AFM) that featured both improved accuracy and higher-throughput 
data acquisition.  This technique was employed to characterize the adhesion strength kinetics 
of Pseudomonas aeruginosa and Staphylococcus aureus.  Both the magnitudes of detachment 
force and rates of increase in adhesion strength were greater for P. aeruginosa than for S. 
aureus.  Furthermore, adhered cells demonstrated a range of adhesion forces that broadened 
with time, indicating that change in adhesion strength does not proceed uniformly. 
 ii
Morphological analyses were conducted to study the antimicrobial properties of nitric 
oxide (NO) against two Gram-negative pathogens. The effects of NO as a function of 
concentration, exposure time, and delivery format were studied using two materials with 
differing NO-release properties.  Analysis of cell topography revealed that higher doses of 
NO correlated with increasing membrane roughness.  Treatment with amoxicillin, an 
antibiotic that compromises the integrity of the cell wall, led to morphologies resembling 
those resulting from NO treatment.  Our observations indicated cell wall deterioration is a 
consequence of NO-exposure for both species studied. 
The combination of NO and silver sulfadiazine (AgSD) was evaluated for bactericidal 
efficacy using a modified broth microdilution technique and a checkerboard-type assay.  The 
combination of NO and AgSD proved synergistic against most pathogens, particularly the 
Gram-positive species.  A highly synergistic effect was produced against S. aureus and E. 
faecalis, including a vancomycin-resistant strain.  The synergistic activity of AgSD and NO 
against a broad range of pathogens advocates future investigation of this therapeutic 
combination for use as a topical anti-infective. 
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Chapter 1: 
 
Introduction to the problem and process of bacterial infection and the 
development of antibacterial agents used to remediate infection 
 
1.1 Bacterial adhesion and infection 
1.1.1 Bacteria as human pathogens.  There are approximately 10 times more bacteria 
living in a human body than there are human cells of which that body is composed.1  
Populations of bacteria colonize the skin, the mouth, and the digestive and genitourinary tract 
of humans.2  Most resident bacteria are harmless, existing in symbiotic relationships with 
their hosts that are either commensal (neither beneficial nor harmful to the host) or 
mutualistic (beneficial to both parties).  In fact, the colonization of the human body by 
innocuous bacteria actually protects against disease by occupying the preferred niches of 
more harmful species, thereby providing a passively beneficial function to the host through 
competitive exclusion.1,2  However, a small fraction of bacteria are pathogenic (infectious 
disease-causing), including many species that constitute the natural flora of the host.2 
 The first level of defense against pathogenic bacteria is provided by physical and 
mechanical barriers such as the skin, the mucosa lining the hollow organs, cilia, and flushing 
mechanisms.3  Once the exterior barriers have been breached, the host immune system 
responds through stimulation of the inflammatory response and recruitment of phagocytes 
(i.e., monocytes, macrophages, and neutrophils) that engulf and destroy the microorganisms.  
Ideally, the skin and the immune system work in tandem to protect against invasion of 
foreign pathogens, although certain events that compromise these defense systems, such as 
removal of the skin barrier (e.g., burns, wounds), introduction of foreign materials (e.g., 
implantation of medical devices), or a weakened immune systems (e.g., human 
immunodeficiency virus (HIV) or cystic fibrosis (CF) patients), leave the host more 
vulnerable to attack from harmful bacteria.   
All clinically significant species of bacteria are chemoorganotrophs (heterotrophs), 
relying upon organic compounds with carbon backbones such as sugars, amino acids and 
proteins for nutrition.4  Pathogenic bacteria cause infection by successfully colonizing animal 
tissue and utilizing the nutritive resources of the host in a relationship that is detrimental to 
the infected organism.  Successful colonization of the host proceeds via four steps:5 
1. adherences at the surface (biomaterial, tissue); 
2. survival at the surface and/or penetration into the tissue; 
3. multiplication within the host; and 
4. undermining, evading, or eliminating the host defense response. 
Infection by a pathogenic species does not always lead to disease expression, and the 
degree of pathogenicity of a microbe is termed its virulence.2  Pathogenic bacteria possess 
characteristics, termed virulence determinants, which support their ability to survive within 
and cause disease to the host.6  Virulence determinants may function by promoting 
attachment and colonization, evading the host immune defense, or damaging tissue.  
Virulence determinants often impart qualities that aid bacterial survival and proliferation 
within a very particular environment, such as in the lungs or on protein-coated material, and 
thus bacterial infections are characteristically localized to a specific area of the body. 
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1.1.2 The bacterial cell envelope.  As the interface between the microbe and its 
surroundings, the cell envelope plays an integral role in determining both the bacterium’s 
ability to colonize and infect its host as well as its susceptibility to various antimicrobial 
agents.  Composed of the cell wall and one or two lipid membranes, the bacterial envelope 
provides shape and structure, governs transport of molecules into and out of the cell, protects 
against numerous environmental stressors, and determines (in part) the degree of 
pathogenicity toward a particular host environment.5  Thus, knowledge of the structure and 
components of the cell wall is integral to understanding the fundamental process of infection 
as well as identifying potential treatment options. 
Pathogenic bacteria are frequently classified according to similarities in the architecture 
of the cell envelope, a system that is particularly useful from a clinical standpoint.  Two 
fundamental types of cell wall exist, which are often differentiated using the Gram stain 
procedure.  Developed by Hans Christian Gram in 1884 prior to elucidation of cell wall 
structure,4 immobilized bacteria are first stained with the positively charged dye crystal 
violet, now known to interact electrostatically with the negatively charged functional groups 
ubiquitous on the exterior of bacteria.7,8  Following subsequent rinses with dilute iodine and 
ethanol solutions, some bacteria retain the initial violet stain (Gram positive) while others are 
decolorized by the ethanol (Gram negative), dependent upon chemical and physical 
properties of the envelope.  A counter-stain, such as the red dye safranin, is frequently 
applied to visualize the otherwise colorless Gram-negative bacteria using a light microscope.4  
The Gram-positive cell envelope is schematically illustrated in Figure 1.1A.  It is a two-
tiered structure composed of a cytoplasmic lipid bilayer surrounded by a thick peptidoglycan 
cell wall.  Peptidoglycan is the fundamental skeletal feature of the bacterial cell wall  
 3
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Figure 1.1  Schematic illustrations depicting cross-sections of the (A) Gram-positive and (B) 
Gram-negative cell wall. 
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comprised of long saccharide polymers crosslinked by peptide chains forming a two-
dimensional, meshed network.  Possessing many layers of peptidoglycan, Gram-positive 
bacteria efficiently retain the crystal violet dye and appear purple after Gram staining.  The 
thick cell wall (constituting 40-60% of the entire cell mass) imparts a tremendous degree of 
rigidity and resistance to mechanical disruption, such that Gram-positive bacteria can 
withstand up to 50 atm of external pressure.5  The peptidoglycan lattice has an estimated pore 
size of 2.2 nm and permits passage of hydrophilic molecules up to ~55 kDa (based on a 
globular protein structure).5  Polysaccharides of mostly anionic character, including teichoic 
acids linked directly to peptidoglycan as well as lipoteichoic acids and lipoglycans tethered at 
the cytoplasmic membrane level (Fig. 1.1A), constitute 10-60% of the cell wall by mass, and 
the high negative charge density serves to bind essential metal cations (e.g., Mg2+, Ca2+, K+).5   
By contrast, Gram-negative species exhibit a three-tiered architecture, with a much 
thinner peptidoglycan stratum enclosed in the periplasmic space between a cytoplasmic 
membrane and a second, outer membrane (Fig. 1.1B).  During the final ethanol rinse of the 
Gram-staining procedure, the outer membrane is dissolved and the peptidoglycan network is 
insufficiently thick to retain the crystal violet dye, decolorizing the cells.  Gram-negative 
bacteria are much more flexible and prone to rupture (resisting only ~5 atm external pressure 
at the maximum) than their Gram-positive counterparts.5   
The outer membrane of Gram-negative bacteria is of paramount importance, primarily as 
it functions as an extraordinarily efficient permeability barrier, with several classes of 
specific and non-specific channel-forming proteins required to facilitate entry of essential 
hydrophilic or charged molecules into the cell (Fig 1.1B).  The exterior leaflet is composed 
of large quantities of lipopolysaccharides (LPS), possessing a hydrophobic segment (lipid A) 
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inserted into the lipid bilayer and a hydrophilic carbohydrate segment that extends out into 
the extracellular environment.9  The hydrophilic portion is constructed of a core 
oligosaccharide, functionalized with numerous phosphate and carboxyl groups, capped by a 
much larger and more variable O-antigen polysaccharide.5  Positioned just above the 
membrane, the layer of polysaccharides poses an additional barrier layer to hydrophobic 
compounds.5  Bacteria deficient in O-antigen exhibit increased susceptibility to hydrophobic 
antibiotics.10  While the structure of the Gram-negative cell envelope renders it particularly 
resistant to penetration by many molecular species, the anionic character of the core region 
attracts positively charged biocides such as aminoglycoside antibiotics or poly-cationic 
peptides like defensins.5 
The sterically massive (up to 65 kDa)9 and negatively charged LPS molecules make the 
outer membrane of Gram-negative bacteria inherently unstable,11 although certain structural 
aspects provide a stabilizing effect.  Specifically, the hydrophobic lipid A portion rich in fatty 
acid chains (~ 6) anchors this bulky molecule into the membrane, while the negatively 
charged functional groups in the core region are typically counterbalanced by divalent 
cations.5  Under stress, vesicles of LPS, sometimes charged with excreted toxins, are shed in 
a process termed blebbing.5  Notably, the lipid A portion of LPS represents an important 
virulence determinant as it is an endotoxin that can cause serious inflammation (e.g., fever, 
septic shock) only when released from the cell membrane during blebbing or lysis.4,5   
Thus, while the Gram-positive cell wall possesses greater rigidity but remains relatively 
permeable to large, hydrophilic molecules, the Gram-negative cell wall exhibits opposing 
characteristics, namely being less resilient to physical stresses but capable of preventing the 
passive diffusion of most molecules across the cell envelope.  Both Gram-negative and -
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positive bacteria frequently produce a gel-like matrix of exopolysaccharides (EPS) called the 
capsule (if attached) or slime layer (if only loosely associated) which surrounds and 
encapsulates the cell, concentrating chemical nutrients and protecting against dessication.4,5  
This feature further elevates the overall virulence of the bacteria by preventing permeation of 
biocides, aiding the evasion of immune detection, and improving surface adhesion.5    Gram-
positive bacteria express a wide range of adhesins as cell-surface proteins that act as 
virulence determinants by promoting adhesion through specific and non-specific binding.  
One example are the M family proteins, which aid in evading phagocytosis and promote 
adhesion to host tissue through specific recognition of and binding to such proteins as 
albumin, fibrinogen, and fibronectin.5  Adhesins are also present on fimbriae, filamentous 
appendages expressed almost exclusively by Gram-negative bacteria whose main function 
seem to be to support adhesion to host sugars via lectin interactions, characterized by very 
specific molecular recognition with regard to both the host and organ (tissue type).5 
1.1.3 Bacterial adhesion to substrata.  Bacteria that are planktonic (free) differ from their 
sessile (attached) form.  While planktonic bacteria are believed to proliferate more quickly 
and exist to spread into new regions, sessile bacteria live in communities focused on 
perserverance.12  It is evident that the exterior surface of bacteria is highly complex, and the 
process of bacterial adhesion to material surfaces has been previously reviewed in detail.13-15  
The number and relative contribution of independent interactions between the bacteria and 
the substrate are dependent upon multiple factors including species,16,17 surface properties 
(e.g., hydrophobicity),16,18-20 adsorption of proteins and other conditioning elements on the 
surface,17,21-24  various experimental system parameters (e.g., temperature, exposure time and 
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conditions),25,26 and the culture environment (e.g., growth phase, ionic strength, pH)14,16,27,28  
under which adhesion occurred.   
The interactions involved in attachment and adhesion are frequently described in basic 
physicochemical terms.  The time-dependent process of bacterial adhesion is often depicted 
as occurring in two distinct phases where a reversible, physicochemical association (Phase I) 
precedes irreversible adhesion through intimate molecular binding interactions (Phase II),29-32 
as shown in Figure 1.2.  Phase I occurs quickly, where a combination of mechanical 
processes including Brownian motion, gravity, implementation of motility structures, and 
chemotaxis (locomotion in response to chemical signals) are first responsible for bringing the 
bacteria close enough to the surface for physical forces of attraction and repulsion to be felt.  
Attachment may then proceed via a combination of physicochemical interactions and long- 
and short-range reversible chemical interactions (i.e., electrostatic attractions/repulsions, 
hydrophobic interactions, and van der Waals forces) that occur along vectors perpendicular 
to the surface (Fig. 1.2A).33  If the net attraction exceeds the repulsive forces, the bacteria 
become ‘irreversibly’ attached to the surface, and enter Phase II of adhesion. 
During Phase II, macromolecules present on the exterior of the bacterium mediate 
attachment to the substratum via cellular and molecular interactions in a complex process 
that extends over a number of hours, signifying the transition from planktonic to sessile states 
(Fig. 1.2B).  The two phases of adhesion differ distinctly.  While Phase I involves 
interactions occurring away from and perpendicular to the surface eventually leading to a 
reversible association, Phase II is characterized by the reinforcement of attachment through 
numerous intimate binding interactions in order to establish a firm adherence of the cell to 
the underlying substrate.  Surface proteins of Staphylococcus subspecies (SSP-1 and SSP-2)  
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Figure 1.2  Schematic illustrating typical interactions involved in (A) Phase I and (B) Phase 
II of bacterial adhesion to a substratum. 
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have been shown to form pili-like structures to mediate attachment to bare plastic surfaces.34  
Motility structures may also prove to be important factors for adhesion, as Pseudomonas 
aeruginosa mutants deficient in flagella have been shown to attach poorly to 
polyvinylchloride (PVC).35  During Phase II, bacteria attain irreversible adhesion to the 
surface and will not spontaneously dissociate. 
In the absence of specific molecular recognition, this process is termed non-specific 
adhesion and may be useful for modeling a scenario where biomaterials become 
contaminated prior to implantation.  Once implanted within the body, bare devices are 
instantaneously coated by a conditioning layer of proteins (e.g. fibrinogen, fibronectin), 
water, and organic molecules, which then mediates both non-specific and specific (receptor-
mediated) interactions (Fig. 1.2B).36  Specific interactions between biomacromolecules of the 
bacteria and host often play an important role in the adhesion process.  Many pathogenic 
bacteria have evolved virulence factors that promote and enhance their ability to successfully 
colonize tissue or protein-coated materials.  For example, alginate is an EPS excreted by P. 
aeruginosa almost exclusively within the lungs of CF patients and constitutes an important 
virulence determinant in this environment.37,38  Furthermore, numerous proteins (e.g., 
lectins), phospholipids, and carbohydrates present on the surface of bacteria are all thought to 
act as adhesins in specific binding events.5,39-41 
1.1.4 Biofilm formation and infection.  Attachment of bacteria to a surface confers the 
dual advantages of permanent residence at a preferential site and subterfuge from host 
defenses.42  Once bacteria have securely attached to a surface, they alter phenotypically by 
aggregating into microcolonies, composed of nearby sessile, daughter, and recruited 
planktonic cells.  Costerton et al.43 have compared these microcolonies to the tissue that 
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composes organs, suggesting they constitute the essential building blocks of biofilms.  
Confocal fluorescence microscopy has illuminated the surprising complexity of biofilm 
structure.44  Biofilm communities form on either biotic or abiotic substrata,12,45 and although 
counterintuitive, biofilms form preferentially in high-shear environments, where lateral 
forces aid in reorganization and strengthening of the underlying structure.46  They excrete an 
EPS matrix, sometimes termed a glycocalyx, that binds them together as a structured 
consortium while trapping nutrients and allowing communication (via quorum sensing) and 
differentiation between cells.  Existence in biofilms also confers resistance to immune system 
defenses as the bound community is too large to phagocytose.47   
Failure of the immune system to control invading pathogens and prevent infection leads 
to an escalated inflammatory response.  Ultimately, pathogenesis of infection may result in 
the self-destruction of the host, e.g., via extended fever, kidney failure due to massive 
deposition of immune complexes, or acute wasting disease caused by the overproduction of 
some cytokines such as tumor necrosis factor.48  Thus, it is imperative to effectively treat 
infections as they arise.  But as the development of antibiotic resistant infections becomes 
more common while the rate of discovery of novel antimicrobials has slowed almost to a 
halt, it is increasingly necessary to prevent infection from forming, therefore sidestepping the 
need for treatment.  Much research in recent years has been devoted to understanding the 
fundamental process of bacterial adhesion to surfaces with the ultimate goal of developing 
surfaces that resist bacterial adhesion.  Hence, there is a simultaneous need both to 
understand the process of infection in order to design the next generation of infection-
resistant biomaterials and to devise novel and effective treatment options for present clinical 
application. 
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1.2 Techniques for studying bacterial adhesion 
As the first step in bacterial colonization and infection, the adhesion of bacteria to a 
substrate is a necessary prerequisite to the development of infection.  Therefore, complete 
elucidation of the fundamental process of bacterial adhesion is the primary hurdle to 
designing adhesion-resistant biomaterials that will prevent infection.  As outlined in Section 
1.1.3, the attachment of bacteria to a surface is a time-dependent process usually described in 
two phases.  Two physical aspects of bacterial adhesion readily lend themselves to 
quantitative study: the affinity for association and the resistance to dissociation.  Appraisal of 
the propensity for attachment relates information on the first stage of adhesion, while 
evaluating resistance to detachment provides insight into Phase II.  
Numerous techniques have been used to study aspects of bacterial adhesion, and these 
have been previously reviewed.49,50  Molecular biology and genetic screening allow the 
identification of specific genes and proteins that are essential to bacterial adhesion.41,51 
Additionally, techniques designed for the empirical observation of bacterial adhesion have 
been applied toward unraveling the complex interactions undergone during the adhesion 
process as well as evaluating substrata for potential biomedical uses.  These employ more 
direct and non-invasive approaches that allow the study of adhesion under controlled 
circumstances and the determination of parameters such as the attachment rate and strength 
of adhesion.   
The choice of bacteria and substrate for adhesion experiments depends on the type of 
problem being investigated.  For example, if the aim of the experiment is to identify 
promising materials for improved hip implants that resist bacterial adhesion, Staphylococcus 
aureus would be a likely candidate as a common and particularly virulent pathogen in 
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orthopedic infections.52,53  If, instead, the goal is to identify proteins that promote the binding 
of S. aureus to blood-contacting devices, then a representative biomaterial would be chosen 
and coated with relevant plasma proteins.  Other experimental conditions that affect bacterial 
attachment include culture growth stage,54,55 pH,56,57 and ionic strength.55-58  
1.2.1 Propensity for attachment.  The proclivity of bacteria to interact and form 
associations with a surface is typically evaluated by determination of the rate of adhesion and 
the overall surface coverage of cells adhered to a substrate.  Bacteria may be exposed to a 
surface under either static or flow conditions.  Static experiments are the simplest to conduct 
and evaluate and involve incubating a segment of substrate within a suspension of bacteria 
for a specified length of time.  The primary limitation to the static procedure is disruption of 
attached cells by an air-liquid interface upon removal for analysis.59  Bacteria may also be 
exposed to a surface using dynamic (flow) systems.   The ability to exchange liquid volumes 
by switching reservoirs of pumped fluid eliminates the need for introducing an air-water 
interface.  Other advantages of using dynamic conditions include ease in obtaining kinetic 
attachment rates, continuous replenishment of bacteria at the surface, and simulation of 
shearing environments (e.g., circulatory systems).  The two devices most commonly 
employed in dynamic studies are the parallel plate flow chamber (PPFC)60 and radial 
stagnation point flow (RSPF) system,55 depicted in Figure 1.3.  For such experiments, the 
substrate may be placed within a chamber over which a bacterial suspension or rinse solution 
flows at a controlled rate.  Differences in the direction of fluid movement inherent to each 
device have been shown to affect the overall number and rate of attachment of bacteria.61  
For example, the RSPF system exhibits a higher initial deposition rate, which has been 
attributed to the convection-controlled mass transport of bacteria to the substrate surface  
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Figure 1.3  Schematic diagrams of (A) a radial stagnation point flow (RSPF) system and (B) 
a parallel plate flow chamber (PPFC). 
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(Fig. 1.3A) compared to the slower, diffusion-controlled transport mechanism characteristic 
of the PPFC (Fig. 1.3B).61  Once surface-bound, bacteria can be detected by myriad 
techniques. 
Microscopy is the most direct method for observing the propensity for attachment.  The 
two parameters primarily determined via microscopy in bacterial adhesion studies are the 
adhesion rate (enumeration of individual cells as they adhere) and the overall percentage of 
the substrate surface area covered.  In addition, patterns of adhesion (i.e., in clusters or 
individually) can be observed.  As bacterial dimensions are on the micron scale, optical 
(light) microscopy (OM) is the most straightforward approach for visualizing adhered cells.  
A substantial advantage of OM is the ability to monitor the rate of bacterial adhesion in 
dynamic studies in real time through the coupling of a digital recording device.  However, 
OM is only applicable to studies that use optically transparent systems (i.e., substrate, media, 
and apparatus), and the resolution limit often leads to difficulty discriminating between 
individual bacteria.  Other methods, such as scanning electron microscopy (SEM), may be 
used to directly observe adhesion to opaque substrates while providing sufficient resolution 
to simultaneously distinguish cellular morphology.  The sample preparation necessary for 
SEM, however, eliminates the possibility for in situ examination. 
Fluorescence microscopy is a particularly powerful technique for studying bacterial 
adhesion that utilizes fluorochromes available in a variety of colors and labeling specificities.  
Blue fluorescent intercalating agents such as 4',6-diamidino-2-phenylindole (DAPI) and 
Hoechst stains readily transverse intact cell membranes and tightly bind to nucleic acids of 
both living and fixed bacteria.  62  Using fluorophore-conjugated biomolecules, molecular 
recognition may be harnessed to label and detect the presence of specific interactions.  For 
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instance, whole cells can be marked and directly visualized using fluorescent antibodies.  
Fluorescence microscopy can also be used to detect and enumerate viable cells.  Combination 
staining with SYTO 9 and propidium iodide can differentiate between healthy bacteria and 
those with compromised membranes.  Similarly, metabolic activity may be monitored using 
fluorescence techniques or by detecting other biochemical markers, such as the production of 
ATP, and is assumed to indicate cell viability.  Bacteria genetically modified to express 
fluorescent tags, such as green fluorescent protein (GFP), propagate the tag through cellular 
division.  This technique allows specific detection of the genetically modified species and 
can be used to monitor growth (e.g., biofilm formation).63  Some additional advantages 
conferred by fluorescence microscopy include rapid enumeration and the reduction of 
operator bias when combined with image analysis software.50   
Viable bacteria may also be indirectly detected by sonication or homogenization of 
substrates with adhered bacteria followed by plating aliquots of the resulting solution on agar 
media.  Each colony grown results from a single viable bacterium recovered from the 
substrate.  While only viable cells may be detected by plating, dead bacteria are also of 
interest as they may possess virulence factors as well as provide specific receptors that 
promote binding and colonization of additional microbes.64  Therefore, a complete technique 
for evaluating the propensity for attachment would enumerate both viable and dead cells.  
Such data may be obtained using fluorescent stains or a Coulter counter. Alternatively, 
radiolabeling bacteria has been implicated as a highly sensitive enumeration technique.65  
While viability cannot be determined as bacteria must be removed from a substrate and lysed 
prior to detection, this technique can be used to accurately determine the overall number of 
adhered cells.  Less common techniques include QCM66,67 and SPR,68,69 which indirectly 
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detect bulk quantities of adhered bacteria and may be applied to determining attachment 
rates. 
1.2.2 Resistance to detachment.  While enumeration of surface-associated cells is more 
useful for understanding Phase I adhesion (where bacteria form a loose association with the 
surface), studying resistance to detachment lends information on the reinforcement of 
adhesion that accompanies Phase II.  The adhesion strength that results from the multitude of 
specific and/or non-specific interactions between the bacterium and the substrate may be 
assessed by applying a measurable force along the surface until the interactions are 
physically disrupted and the bacteria detach.  This is key to understanding how difficult the 
removal of pathogenic bacteria from a bare surface (e.g., a device prior to implantation) may 
be once adhesion occurs, or how bacteria adhered to a protein-coated material (e.g., an 
implanted device) behave when exposed to biologically relevant forces such as the shear 
stresses of blood flow or the mechanical impact resulting from patient movement.  
Additionally, determining how adhesion strength changes as a function of time yields 
important information on the fundamental behavior of bacterial interactions with surfaces. 
Lateral forces may be applied using techniques such as micromanipulation to induce 
mechanical disruption (particularly useful for measurement of biofilm adhesion 
strength),54,70,71 the air-liquid interface introduced by a passing air bubble,72 or most 
commonly by applying shearing forces with laminar flow.19,61,73-75  As bacteria are essentially 
charged colloids, an electrophoretic technique has also been reported for determining the 
strength of adhesion based upon the applied electric field required to detach cells.76  These 
techniques are limited by the inability to simultaneously control both the magnitude and 
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location of applied forces, with the exception of micromanipulation, which possesses a limit 
of force detection that exceeds that achieved by individual bacteria. 
The same principle behind the dynamic systems (e.g., PPFC and RSPF) used to study 
bacterial attachment rates may be modified to apply lateral forces to detach adhered bacteria 
using laminar flow, and detachment is easily monitored using light microscopy.  Using a 
microjet impingement technique closely related to RSPF, the adhesion strength of 
Pseudomonas stutzeri was shown to be 2- to 3-fold greater on hydrophobic indium tin oxide 
coated substrates relative to bare hydrophilic glass, agreeing well with theoretical 
predictions.73  A PPFC was used to evaluate the effect of shear stress on receptor mediated 
adhesion of S. aureus to collagen coated substrates as a function of flow rate and densities of 
both receptor and ligand.77  Another hydrodynamic approach involves the use of a spinning 
disk, where the applied shear stress during rotation is a function of the density and viscosity 
of the fluid as well as the angular velocity, which varies linearly with the radial distance.74 
Recently, atomic force microscopy (AFM) has emerged as the prominent technique for 
studying the forces of bacterial adhesion.  Overall, AFM has surpassed flow cells in 
publications related to bacterial adhesion after the year 2000 (138 vs. 129), while among the 
techniques used to study individual forces of adhesion, it far exceeds the publication numbers 
for optical tweezers (25).  AFM has gained this prominence through being particularly 
versatile.  Traditionally, AFM has been used to probe interaction forces perpendicular to the 
substrate, generating curves of force felt by the AFM probe as a function of distance between 
the probe and the surface measured in the z-direction.  In terms of understanding bacterial 
adhesion, surface-adhered bacteria have been probed using bare or modified AFM tips.57,78-80  
Conversely, bacteria have been used to probe various surfaces by covalently crosslinking 
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them either directly onto the AFM probe81-83 or to a colloid that is subsequently attached to 
the tip of a cantilever.84,85  Of particular interest, bacteria-modified cantilevers can be used to 
survey for low-biofouling surfaces.86   
While the versatility and control over the interactions investigated using AFM is 
unprecedented, force measurements acquired normal to the surface have generally been 
restricted to acquiring data in the early stage of adhesion, ranging from attractive or repulsive 
interactions felt during approach to the force of detachment following physical contact over 
perhaps the first few seconds or minutes.  Bond strengthening has been shown over the short 
term using AFM force spectroscopy.87-89  Long-term adhesive forces have not been evaluated 
using this method, primarily due to low throughput.  Only one vertical force measurement 
may be obtained per increment of time over which adhesion strength is to be evaluated. 
More recently, a technique for applying a lateral force to adhered bacteria using AFM has 
been reported.90-93  Here, bacteria adhered to a substrate are mechanically detached by an 
AFM probe scanning over the substrate, and this technique allows for analysis of many 
bacteria simultaneously, while maintaining control over the applied force.  Detection of 
bacteria and bacterial detachment can be simultaneously monitored if the lateral forces are 
applied while imaging (contact mode).  This method has been used to compare the effect of 
surface roughness/topography91,93 and surface hydrophobicity92 on the strength of bacterial 
adhesion, drawing empirical relationships between the normal force between the probe and 
the underlying substrate (assumed constant due to feedback loop adjustment).   Later 
modifications to this technique introduced a more quantitative approach for determining the 
force applied to bacteria, applying it to monitor the long-term (Phase II) kinetics of adhesion 
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strength of P. aeruginosa and S. aureus over an 8 h time period (18-26 h after initial 
attachment).90 
 
1.3 Antibacterial agents 
It wasn’t until the revolutionary introduction of germ theory in the latter half of the 19th 
century, spearheaded by such luminaries as Louis Pasteur and Robert Koch, when the 
connection was finally made between microorganisms and disease.  Infections were 
relatively common occurrences, but rarely treatable and frequently deadly, and, therefore, 
viewed with a degree of superstition.  Once microbes, invisible to the naked eye, were finally 
recognized as causative agents, doctors could begin to search for strategies to circumvent and 
treat infection.  Vaccination against disease is one ingenious stratagem that obtained 
prominence with the acceptance of germ theory and has resulted in the prevention of 
countless infections.94  Injection of a small amount of antigenic material (attenuated or 
inactivated pathogen) stimulates the immune system to produce antibodies that quickly 
recognize and bind to characteristic epitopes, tagging the microbe for destruction.94  More 
frequently used to prevent viral infection, immunization has also enjoyed some success in 
preventing bacterial infection (e.g., tetanus, anthrax).   
With the introduction of penicillin into clinical practice, hailed as the so-called ‘magic 
bullet,’ it seemed like bacterial infection was under control for the first time.1  The 
Penicillium fungi had evolved the production of this molecule specifically to elicit 
bactericidal action, and penicillin could be used to rapidly cure infections caused by Gram-
positive pathogens with no toxic effects.  The natural products of thousands of 
microorganisms were intensively screened and additional drug candidates identified.  
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Ironically, it soon became evident that these drugs, when used inappropriately, became the 
selective pressure responsible for promoting the emergence of resistant species.  Thus, there 
is always a drive for the discovery of new antibacterial agents and the identification of novel 
treatment options in the ongoing race to fight infection.   
1.3.1 General overview of antibiotics.  Antibiotics are a broad class of antimicrobial 
agent derived directly from microbial species that inhibit the growth of other microbial 
species.  The production of antibiotics evolved as a partial solution to microbial competition 
for space by poisoning nearby microorganisms that vie for the same nutrients.95  While 
conferring a selective advantage to antibiotic-producers, biofilm formation and other 
resistance mechanisms co-evolved as a protective response.45  Classification as an antibiotic 
also requires that the natural products possess low molecular weights and efficacy at low 
concentrations.95  Hence, neither lysozyme nor ethanol, both products of microorganisms 
with biocidal effects, is considered to be an antibiotic.  Although antibiotics technically refer 
to an inhibitor of the growth of any microbe (e.g., bacteria, fungi, protozoa), only bactericidal 
antibiotics are considered here.   
For therapeutic application in treating infectious disease, antibacterial agents should 
possess certain characteristics.95  Of primary importance is a high level of efficacy (the 
ability to efficiently eradicate infectious pathogens) combined with minimal harmful side 
effects to the patient.  A drug should also possess good bioavailability, or distribution to the 
infected part of the body, and elimination properties.  The overall risk and toxicity to the 
patient should be low.  Other preferable characteristics include that the drug be inexpensive 
to produce and exhibit activity against a range of pathogens.  Around 10,000 antibiotics have 
been discovered, although only a small percentage of them have proven useful in treating 
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infectious disease.  Antibiotics function by molecular recognition of and specific binding to a 
macromolecule or cellular component that performs a vital function within the bacteria.  If 
the effects are lethal, the antibiotic is bactericidal, while if the growth of the bacteria is only 
inhibited (usually reversibly), the antibiotic is bacteriostatic.  The major targets for antibiotic 
action are cell wall biosynthesis, protein biosynthesis, and DNA replication and repair. 
Antibiotics are frequently classified into families based upon common chemical structure 
and biological properties, which are generally named after the first antibiotic of the family to 
be discovered.95  The principle classes included β-lactams (penicillins), tetracyclines, 
aminoglycosides, macrolides, ansamycins, as well as certain peptides and glycopeptides.  In 
order to improve action, bioavailability, or circumvent resistance to these natural products, 
pharmaceutical scientists have introduced minor modifications while preserving the structure 
of the active regions, and many semi-synthetic analogs have been successfully used to treat 
infection.  For example, ampicillin and methacillin are two well known variants of penicillin, 
all three possessing the β-lactam ring structure that inhibits peptidoglycan synthesis.  Finally, 
there are three families of fully-synthetic antibiotics used clinically: the sulfonamides, 
introduced in the 1930s; quinolones, introduced in the 1960s, and oxazolidanone, approved 
by the FDA in 2000.95  To date, a virtual encyclopedia of information has been accumulated 
on biometabolism, structure/function relationships, mechanisms of action and of antibiotic 
resistance, bioavailability, therapeutic uses and treatment protocols of the various 
antibiotics.95,96  
Antibiotics are popularly prescribed due to their high selectivity and low-dosage 
requirement, but due to the tendency for overuse, the co-evolution of numerous genetic 
resistance traits, and rapid adaptability of bacteria when faced with new stressors, it now 
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appears that antibiotic use in the sense we know it today will be of limited use.1  The 
discovery of new antibiotics is slow.  Identification of key bacterial targets helps direct 
attempts at developing new synthetic antibiotics, but with limited success.  Furthermore, the 
introduction of a safe and effective new antibiotic has historically led to widespread use and 
subsequent development of resistance.95  It is evident that antibiotics are losing their 
effectiveness for fighting infection, and other therapeutic options must be developed.  Two 
candidates with proven antibacterial efficacy, ionic silver (Ag+) and nitric oxide (NO), are 
discussed in detail below. 
1.3.2 Ionic silver and silver compounds.  With records dating back thousands of years, 
silver is perhaps the antimicrobial with the longest history of use by man.97  Nano- to 
micromolar concentrations exhibit broad-spectrum bactericidal activity, showing efficacy 
against Gram-negative and -positive species including those resistant to traditional 
antibiotics.98-101  Ag+ reacts covalently with electron-donating groups (e.g., cysteine) and 
electostatically with negatively charged molecules (e.g., DNA).  While the promiscuous 
reactivity of this species raises questions of toxicity to the host, centuries of use combined 
with modern clinical studies indicate that therapeutic doses of Ag+ do not pose a serious 
health risk for humans.97,98  For example, the minimum dose of silver nitrate (AgNO3) 
causing inhibition of respiration in skin tissue culture was shown to be 25-fold greater than 
the quantity required to inhibit growth of P. aeruginosa,102 a common pathogen in burn 
patients.  The broad-spectrum activity exhibited against a wide range of microorganisms, 
including antibiotic-resistant species, ensures the continued interest in developing novel 
silver treatments, particularly for topical applications (e.g., burn and wound management).100 
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Storage of water in silver vessels was a common practice in ancient times.  Silver in its 
solid, metallic (Ag0) form is unreactive, and bacterial toxicity is limited by the rate of 
oxidation to the biologically active state (Ag+).   While this rate may be adequate to 
neutralize the relatively few microbes that might be present in drinking water to a sanitary 
level, bacterial infections are characterized by microbial densities of at least 105 organisms 
per gram of tissue mass.99   The clinical solution for effective topical delivery of Ag+ has 
been the use of silver compounds, particularly AgNO3 (Fig 1.4A) and silver sulfadiazine 
(AgSD) (Fig 1.4B).  These compounds, used clinically for over 40 years, represent the gold 
standard in silver delivery systems, releasing 3.8 x 104 (0.5% solution) and 1.6 x 104 (1% 
solution) µg Ag+ in-2 d-1, respectively.99  Their nearest market competitor (in levels of Ag+ 
released) is nanocrystalline silver, a metallic solid possessing high surface-to-volume ratios, 
though the quantity of Ag+ delivered is almost two orders of magnitude lower.99  The primary 
advantage of the nanocrystalline delivery formulation relates to its anti-inflammatory 
properties,103,104 as prolonged inflammation can be deleterious to the wound healing 
process.99 
Gram-negative bacteria are typically more susceptible to the effects of Ag+.100,105-107  
Feng et al. attributed this to the protective nature of the thicker peptidoglycan layers 
possessed by Gram-positive species.105  A screen of the efficacy of AgSD against 657 
clinical isolates representing 22 bacterial species clearly demonstrated the susceptibility of 
Gram-negative species.100  The authors pointed out the remarkable resistance displayed by 
Enterococci as a group, though surprisingly did not comment further on the overall trend of 
higher Gram-negative susceptibility evident in their data.100  They did conclude that the most 
relevant pathogens for burn and wound infections were susceptible to doses of AgSD that  
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Figure 1.4  Molecular structures of the compounds (A) silver nitrate (AgNO3) and (B) silver 
sulfadiazine (AgSD), commonly used for the topical delivery of Ag+. 
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were easily achieved topically.  Unfortunately, despite its efficacy, resistance to Ag+ has been 
documented.97,108-110  As with antibiotics, the expression of Ag+-resistance primarily becomes 
a problem when the infection is treated with sub-bactericidal levels.99  Li et al. showed that 
silver-resistant mutants of Eschericia coli could be cultivated in vitro through a step-wise 
exposure and selection procedure using low levels of AgNO3.108  The mechanism of Ag+ 
resistance is thought to lie at the cell envelope level111 and there is evidence of both porin 
deficiency and active efflux of Ag+ in E. coli.108 
The mechanism of bactericidal action of Ag+ is still not clear.  This is partially due to the 
broad level of reactivity, with numerous target sites and subsequent chains of cause-and-
effect that are potentially interwoven.  To complicate the elucidation process, the changes 
elicited from in vitro experiments with AgNO3 differ somewhat from those observed when 
AgSD is used.111-113  However, significant progress has been made in elucidating certain 
aspects of Ag+ toxicity.  One comprehensive set of studies aimed at elucidating the 
mechanism of AgSD activity utilized radioactive elements to trace the presence of 110Ag in 
various cellular components (i.e., lipids, proteins and polysaccharides, and nucleic acids) of 
P. aeruginosa and verified that the majority of Ag+ reacts with proteinaceous functional 
groups.114,115  It is well known that thiol groups readily bind covalently to heavy metals such 
as Ag+, and Liau et al. showed that the addition of compounds containing free thiol groups 
neutralized the bactericidal activity of AgNO3 against the same species.116  Adsorption to 
proteins inhibits their ability to function, and Ag+ has been implicated in causing both 
structural and metabolic disruption to bacteria.112,117 
Most of the bacterial target sites of Ag+ probably lie in the vicinity of the cell 
membrane.117,118  It has been shown that Ag+ associates with cell wall components.105,117  
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After treatment with AgNO3, electron-rich conglomerations on the order of tens of 
nanometers deposited around the cell wall of E. coli were visualized using transmission 
electron microscopy (TEM).105  Images of E. coli and S. aureus treated with AgNO3 also 
clearly showed detachment of the cytoplasmic membrane from the cell wall structure.105  
Using the same technique, AgSD-sensitive Enterobacter cloacae and P. aeruginosa 
demonstrated abnormal morphologies (e.g., blebbing) after exposure to this compound, while 
AgSD-resistant strains did not exhibit these changes.111,119 
The effects of broad-scale membrane-oriented protein deactivation are not limited to 
structural damage.  Importantly, a number of studies indicate that low concentrations of Ag+ 
(≤ 10 µM) inhibit cellular respiration in bacteria by decoupling the respiratory chain from 
oxidative phosphorylation, resulting in a lethal deenergization of the cell.118,120-122  Dibrov et 
al. showed that treatment of Vibrio cholerae membrane vesicles with AgNO3 caused a 
massive proton leakage and subsequent collapse of the proton gradient across the membrane 
ultimately dissipating the proton motive force.120  Further evidence that Ag+ affects electron 
transport at the membrane was provided by Holt and Bard,118 who demonstrated that AgNO3 
caused an initial stimulation followed by a complete cessation of respiration in E. coli. 
In addition to adsorption at the cell membrane level, some studies indicate that Ag+ 
penetrates the bacterial cell and interacts directly with cytoplasmic proteins and DNA.  TEM 
showed condensation of chromosomal DNA after treatment with AgNO3, purportedly 
inhibiting replication and division.105,119  Complementary analyses of electron-dense granules 
in the vicinity using X-ray microanalysis positively identified both Ag and S, suggesting that 
Ag+ interacts with intracellular protein thiols as well.105  Cell fractionation experiments of P. 
aeruginosa treated with radiolabeled silver compounds showed a positive correlation 
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between growth inhibition and the quantity of DNA-associated Ag+, despite the low level of 
interaction relative to Ag bound to the protein fraction. 
1.3.3 Nitric oxide and NO-donors.  Nitric oxide is a highly reactive, diatomic free 
radical endogenously produced by the enzyme nitric oxide synthase (NOS), which catalyzes 
the oxidation of L-arginine to L-citrulline.123  NO has been implicated as a mediator in 
diverse physiological processes, ranging from regulatory roles in the cardiovascular and 
nervous system to the inducible host response to infection.124,125  Various therapeutic 
properties attributed to NO, including tumor cytotoxicity,126,127 vasodilation, and improved 
wound healing and tissue integration at implant sites128  may prove beneficial in a number of 
pharmacological applications.129,130  In particular, the antimicrobial properties of NO, an 
essential part of the body’s endogenous first line defense against foreign pathogens,131,132 are 
of interest as a therapeutic option for the treatment of infection.  The very fact that this role is 
conserved133 yet continually effective implies a limited ability on the part of bacteria to 
develop resistance to the antimicrobial action of NO.  In terms of NO-tolerance, low 
molecular weight thiols play a role in scavenging NO in bacterial cells,131 while E. coli, S. 
aureus, and Salmonella typhimurium bacteria have been shown to upregulate the production 
of certain proteins in the presence of NO in order to resist NO-mediated damage.134-137  
However, it is unlikely that bacteria possess mechanisms sufficient to tolerate therapeutic 
doses of NO, as these are much higher than the quantities produced endogenously by the 
host’s immune system. 
Like Ag+, NO is a broad-spectrum antibacterial agent of somewhat dubious mechanisms 
and is known to react either directly or indirectly with cysteine residues and transition-metal 
centers of proteins, DNA, and lipids.131,138,139  The effects of direct NO-modification are 
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more prominent at low concentrations (<1 µM) and include reaction with metal and metal-
oxygen complexes (including hemoglobin) as well as other high energy radicals.138  At 
concentrations in the micromolar range and above, NO elicits indirect effects through the 
formation of reactive nitrogen oxide species (RNOS) that then render nitrosative and 
oxidative stresses upon biomolecules.138  Oxidative stresses involve hydroxylation reactions 
as well as the withdrawal of 1 to 2 electrons from a substrate.138  Nitrosative stress may refer 
either to nitrosation by the addition of NO+ to an amine or thiol or to nitration of aromatic 
groups by the addition of an equivalent of NO2+.138  When NO reacts with oxygen (O2) or 
superoxide (O2-), species commonly encountered near bacteria lipid membranes, highly 
reactive RNOS intermediates are formed.131,138,140  Reaction with O2 forms nitrogen dioxide 
(NO2) and dinitrogen trioxide (N2O3), which primarily function via deamination of 
nucleotides and nitrosation of thiols and amines.138,140,141  The strong oxidant peroxynitrite 
(ONOO-) is formed by reaction with O2- and has been implicated in the radical lipid 
peroxidation leading to membrane degradation in addition to deleterious modification of 
proteins and DNA.131,138  Despite a solid understanding of the types of reactions undergone 
by NO and RNOS, it is not clear which target sites are critical for bactericidal activity.131  
Considering the lipophilic nature of NO and the proximity of O2 and O2- to the cytoplasmic 
membrane,140 it is likely that many targets are concentrated in this vicinity. 
Due to its high level of reactivity, diverse regulatory roles, diffusibility,142 and short half-
life in blood (< 1 s),143 the ability to target therapeutic NO delivery locally is critical.  
Gaseous NO (gNO), delivered from a cylinder of compressed gas, has been evaluated for 
topical application144 and as a potential treatment of pulmonary infections via direct, 
intermittant inhalation of gNO diluted in medical-grade air.145,146  For treatment of infections 
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that are not directly available for gNO exposure, a NO-delivery system is needed.  Nitric 
oxide donating compounds, such as S-nitrosothiols147,148 and N-diazeniumdiolates,129 
decompose to release NO and hence serve as vehicles for its storage and transport (Fig. 1.5).  
As the name suggests, S-nitrosothiol functionalities, usually abbreviated RSNO, consist of an 
NO group bonded directly to a sulfur atom and embody the endogenous solution to the 
problem of NO storage (Fig. 1.5A).  Release of NO from RSNO is catalyzed by light, heat, 
metal ions, or via direct transfer to a second thiol.148,149  Most RSNO also decompose 
spontaneously, and their inherent instability limits their shelf life.148,149  N-Diazeniumdiolates 
(NONO-ates) represent a second class of NO-donor functionality that store NO on primary or 
secondary amines (Fig 1.5B).143  Stable at low temperatures and in aprotic environments, 
diazeniumdiolate moieties rapidly decompose into two equivalents of NO under 
physiological pH and temperature (regenerating the parent amine), a characteristic of clinical 
significance.129 
A number of materials, including nanoparticles,150,151 films and coatings,152,153 and small 
molecules,154,155 have employed diazeniumdiolate chemistry with varied physicochemical 
and NO-release properties that are dependent upon the structure of the NONO-ate as well as 
the chemical environment provided by the material backbone.156  Stabilizing effects may be 
provided, for example, by nearby positively charged amines or by protection of the moiety 
from solvent (e.g., within a xerogel polymer matrix), slowing decomposition according to the 
rate of water permeability.  By contrast, many small molecule donors such as 
diazeniumdiolate-modified proline (PROLI/NO)155 possess a very short half life in water 
since the protic solvent has ready access to the diazeniumdiolate moiety.  Tuneable NO-
release properties are a key feature of diazeniumdiolate-modified materials as it allows  
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Figure 1.5  Molecular structures of representative NO-donor compounds.  (A) S-
Nitrosothiol-modified penicillamine (SNAP) and (B) N-diazeniumdiolate-modified proline 
(PROLI/NO) store one and two equivalents of NO per molecule, respectively.   
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control over both duration and dose of therapeutic NO delivered.156 
The antimicrobial properties of NONO-ate materials have been characterized against a 
number of pathogenic bacterial species, including Gram-negative, -positive, and antibiotic-
resistant species.107,157-159  Nitric oxide released from xerogel coatings have been shown to 
reduce the rate of bacterial attachment158,160,161 while killing those that do adhere.158  As 
would be expected, a positive correlation exists between the dose of NO and the level of 
antibacterial activity.107,157,158  Short-term delivery of NO via a bolus results in a higher 
degree of cellular damage than equivalent doses delivered more slowly as a sustained, but 
localized, surface flux.157  However, a localized bolus delivery of NO from nanoparticles was 
shown to be more effective than a dissipated, but higher concentration, bolus dose from 
PROLI/NO.159  Therefore, both the dose of NO and the proximity of NO release to the 
pathogens appears to be important for antibacterial efficacy.  Nitric oxide-releasing 
nanoparticles have also proven effective against day-old biofilms of Gram-negative and -
positive species in addition to an infectious species of yeast (Candida albicans).162  At 
bactericidal levels, the toxicity of NO against mammalian cells is low,145,159 and in some 
cases has been shown to promote proliferation of epithelial cells and increase survival of 
macrophages.145  Therefore, materials that store and release NO are very promising for their 
potential to both reduce the likelihood of initial bacterial attachment and treat established 
infection. 
 
1.4 Techniques for evaluating antimicrobial activity 
1.4.1 Morphology.  Bacteria, though invisible to the naked eye, are of very convenient 
dimensions for viewing microscopically.  Further, healthy cells of a particular species have a 
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relatively standard outer appearance.  Thus, with the introduction of high-resolution 
microscopes such as SEM, TEM, and AFM, scientists have the tools to directly observe 
antibacterial effects.  Morphological analyses of bacteria aid in understanding mechanisms of 
antibiotic action by allowing visualization of changes in the appearance of the microbe 
undergone subsequent to treatment.  The images obtained using electron microscopy are 
primarily utilized to obtain qualitative comparisons.  For example, dose-dependence can be 
monitored as a function of concentration or exposure time.  In addition, antimicrobials that 
function by similar mechanisms can be compared.  With the introduction of AFM for 
morphological evaluation, semi-quantitative information on changes in bacterial surface 
roughness could be obtained simultaneously with high-resolution three-dimensional 
reconstructions of cell morphology.157,163  An added benefit of AFM is the flexible and 
adaptable nature of cantilevers as transducers that allow detection of other physical (e.g., 
elasticity) or chemical (e.g., charge distribution) surface parameters simultaneously with the 
acquisition of height information.57,78,163,164 
Changes in appearance, or morphology, of bacteria exposed to various antimicrobials 
have been frequently reported since the 1970s.105,111,112,165-168  As described in Section 1.3.2, 
TEM was vital for demonstrating the structural damage wrought by Ag+ on Gram-negative 
and -positive species and well as visualizing adsorption to DNA.105,111,112  Klainer and 
Russell166 used SEM analysis to show that two antibiotics that inhibit protein synthesis 
(chloramphenicol and streptomycin) rendered a similar spectrum of morphological changes 
on E. coli.  Another study compared the effects of two β-lactam antibiotics amoxicillin and 
ampicillin on E. coli, and found a correlation between morphology and the superior activity 
of amoxicillin.168 
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While electron microscopy has been employed toward this end for decades, atomic force 
microscopy (AFM) has recently been used with increasing frequency.169-174 As a surface 
characterization tool, AFM is ideal for morphological studies of surface-adhered bacteria as 
it allows cells to be imaged in situ with high resolution without requiring chemical drying, 
metal coating, or exposure to ultra-high vacuum.  Atomic force microscopy has been applied 
to visualizing the antimicrobial action of peptides,169,171,173 chitosan,170 quantum dots,172 and 
the β-lactam antibiotics penicillin and amoxicillin.174  It has also been used to monitor the 
dose-dependence of NO on cell roughness and to compare the efficacy of two NO-donor 
delivery methods.157 
1.4.2 Efficacy.  While microscopy is very useful for visualizing the effects of biocides, 
it is very important from a clinical standpoint to evaluate antimicrobial efficacy in 
quantitative terms.  To be clinically effective, it is essential that therapeutic drug 
concentrations are achieved at the site of infection.  Pharmacodynamics represent the dose of 
an antibacterial agent necessary to elicit bacteriostatic (inhibitory) or bactericidal effects.175  
The interaction between the drug and the patient’s body, or the pharmacokinetics, also plays 
a role in overall efficacy.  Pharmacokinetics encompasses absorption, biodistribution, 
metabolism and elimination of the drug by the patient.175 Parameters describing the 
pharmacokinetics and pharmacodynamics of an antibiotic help quantify the degree to which a 
treatment will be effective against infection.  
Due to the broad medical application and need for consistency, there are relatively 
standardized techniques for evaluating the efficacy of an antibacterial.176  In determining the 
pharmacodynamic interplay between a target microorganism and antibacterial agent in vitro, 
the minimum inhibitory concentration (MIC) and/or the minimum bactericidal concentration 
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(MBC) are generally determined.177  The classical approach for evaluating the antibacterial 
efficacy of a biocide is determination of the MIC, or the drug concentration sufficient to 
arrest further growth of the bacteria in nutrient broth.  A common technique is the 
microdilution broth method, where the MIC is determined by inoculating a vial of bacteria 
(at concentrations below detection via optical density) with a series of concentrations of the 
drug and allowing growth at 37 °C overnight.177  The MIC falls between the lowest 
concentration vial retaining transparent media and the highest concentration vial exhibiting 
visible turbidity.177  A similar approach utilizes solid media prepared with two-fold, stepwise 
dilutions of the antibacterial.  Bacteria are spread upon the agar surface, and inhibition is 
determined by the lowest concentration that inhibits colony growth.96 
Inhibition of growth, however, does not indicate bactericidal doses.  In fact, inhibitory 
doses often have reversible effects, and treating infection-causing bacteria with sub-
bactericidal levels tends to select for and allow further growth of mutants and naturally 
resistant strains.  Common methods for evaluating the bactericidal activity of an 
antimicrobial are killing curves and determination of minimum bactericidal concentration 
(MBC).177  Determination of the MBC is more clinically useful, though more work intensive, 
than the MIC.  The MBC, usually conducted by counting colony-forming units (cfu) grown 
on agar plates before and after treatment, was historically determined by plating an aliquot of 
each vial containing transparent media following an MIC assay.  The lowest concentration of 
bactericidal agent capable of eliciting a 3-log reduction in viable bacteria is the MBC, and 
any higher concentration should be bactericidal as well.177 
Evaluating efficacy using in vitro infection models is fast and inexpensive, and the main 
disadvantage lays in the simplicity of the system (also an advantage). For instance the 
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conspicuous absence of the immune system means that contributions to efficacy from 
endogenous defenses cannot be evaluated in concert with the antibiotic.175  It is also known 
that bacteria in vitro grow faster and express decreased levels of virulence.178  Additionally, 
the microdilution broth methods to determine MIC and MBC values evaluate inhibition and 
viability of planktonic cells, which are faster-growing and more susceptible to antimicrobials 
that disrupt metabolic processes than would their sessile, slow-growing counterparts.  
Although it is more convenient to study planktonic cells, it is also important to evaluate 
antimicrobial efficacy on biofilms. 
Biofilms (Section 1.1.4), characterized by sessile communities of bacteria, are commonly 
associated with recurrent, chronic, and device-related infection and are responsible for an 
estimated 60% of human infections.45  The evolution of matrix-encased, cooperative 
community organizations that reduce susceptibility to antibiotics (natural products) was 
certainly advantageous in the microbial competition for space in nature.  This protective 
advantage has been carried over to infectious biofilms,45 rendering them notoriously difficult 
to treat.  The underlying causes of reduced susceptibility of biofilms is multifactorial and not 
fully understood: the EPS encapsulating the biofilm renders them relatively impermeable to 
most antibacterials; cells in a biofilm exhibit decreased rates of growth and metabolism; 
alterations in phenotypic and genotypic expression of sessile bacteria may affect their 
sensitivity; and, finally, the rather ambiguous theory of the persister cell that expresses a 
temporary tolerance to antibacterials due to the necessity to survive under stress.  
Biofilms often require from 10 to 1,000-fold greater concentrations than planktonic 
bacteria to achieve efficacy.179-182  Based upon the poor correlation in efficacies obtained for 
planktonic vs. biofilm bacteria and subsequent difficulties in predicting the therapeutic 
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outcome of treating suspected biofilm-related infections using planktonic (MIC or MBC) 
determinations, a new procedure was necessary to present quantitative information regarding 
the reduced susceptibility of biofilms.45  The minimum biofilm eradication concentration 
(MBEC) assay was thus designed to assess antimicrobial efficacy against these surface-
associated communities.45,179,182,183  Briefly, equivalent biofilms are grown simultaneously in 
each well of a 96-well microtitre plate.  After exposure to antibacterial agents for 24 h, the 
biofilm is removed via sonication and transferred to sterile nutrient broth.  The MBEC is the 
lowest dilution of biocide at which bacteria fail to regrow. 
1.4.3 Combination therapy.  Resistance to standard antibiotic treatments is a growing 
problem and resistance to all clinically used antibiotics has been documented, while the 
discovery of novel antibiotics or synthetic antibacterial agents is a slow process.1  Elucidation 
of the genes and proteins essential for bacterial vitality allows us to pinpoint specific targets 
in order to intelligently design and assay potential new treatment options.95  Bacteria faced 
with a new antibacterial agent must adapt or die.  Unfortunately for us, the rate at which 
bacteria divide is exceptionally fast.  Though adaptation through mutation is slow for most 
organisms, bacteria quickly adapt to new agents, developing resistance mechanisms that 
allow them to flourish.  As bacteria often share genetic material, the genes that code for 
resistance may be passed not only to the offspring of the resistant mutant, but also to other 
bacterial species, particularly those that reside in close proximity either on the body of the 
patient or in the nearby community.1,184  Due to the pressing problem of resistance, there is a 
continual need for the introduction of novel treatment options.  Until the time that it becomes 
possible to prevent infections from forming, it is necessary to treat infections that do form 
while taking care to stave off developing resistance. 
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One approach is combination therapy, the concerted use of two or more antibacterial 
agents.  There are numerous benefits to using antimicrobial combinations.  One reason is to 
enhance the spectrum of activity through multiple mechanisms of action, and this may be 
particularly useful when treating polymicrobial infections, such as wound beds, or seriously 
ill patients.185  The presence of multiple bactericidal mechanisms also reduces the likelihood 
for resistance to develop, in addition to allowing treatment of infections that may already 
express some resistance to one of the agents.  One final advantage to combination therapy is 
the potential to minimize any toxic effects imposed by the individual antibacterial agents.185  
If the effects of combined usage are at least additive, then only half the dose of each 
individual biocide in combination would be necessary to elicit the response garnered from 
the full dose of either agent independently. 
Synergy between agents is another possible outcome of combination therapy.  Synergism 
is achieved when the coincident use of two agents is characterized by a greater than additive 
effect than when the agents are dosed individually.  This may be expressed as a greater rate 
of action or in the absolute magnitude of bacterial killing.186  In order to intelligently predict 
advantageous combinations, knowledge of the mechanisms of action of individual agents is 
important.187  Synergistic combinations represent a particularly attractive avenue for slowing 
the rate of emerging resistance, possessing all the advantages of combination therapy in 
addition to further reducing potential toxicity by requiring even smaller doses.  Depending 
upon the mechanism of action, the use of synergistic combinations may also further reduce 
the probability of emerging resistance.186 
One route to attain synergy involves combining a cell permeabilizer with an agent that 
functions primarily within the cytoplasm, with the end goal of improving the accessibility of 
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the target to the biocide.  For example, the combined use of penicillin, a cell wall-active 
agent, and the aminoglycoside streptomycin has synergistic activity against most Gram-
positive bacteria, including Enterococci,188,189 Streptococci,190 and Staphylococci,191 as well 
as some Gram-negative bacteria.192,193  Other agents that enhance membrane permeability, 
such as p-aminobenzoic acid (PABA)194 and positively charged glycopeptides,195 have 
successfully been combined with intracellularly active agents to produce synergy. 
Another synergistic mechanism is brought about if one agent serves to protect the second 
agent, for example, through inhibition of a modifying enzyme.  One resistance determinant 
currently expressed by many bacteria is the β-lactamase enzyme, which hydrolyzes and 
cleaves the β-lactam ring of penicillin-like antibiotics.  In an attempt to circumvent the 
detrimental effect of this enzyme, much research has focused on developing analogs that 
express a lower affinity for the β-lactamase and numerous generations of β-lactam family 
have been generated.95  Another approach to overcoming the β-lactam resistance utilizes the 
synergistic combination of a β-lactamase inhibitor, a molecule possessing a higher affinity 
for the enzyme, used in concert with a typical β-lactam antibiotic.196 
The sequential blockage of steps in a metabolic pathway has also been shown to elicit 
synergistic activity.  The combination of trimethoprim with a sulfa drug such as 
sulfamethoxazole or sulfadiazine exhibits synergistic activity by inhibiting two important 
enzymes that synthesize folic acid (dihydropteroate synthetase and dihydrofolate 
reductase).197,198  While each agent is typically bacteriostatic when used independently, the 
combination elicits bactericidal activity and is effective against a wide range of pathogens 
(both Gram-negative and -positive species).185,199 
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The synergistic activity between two biocides is typically evaluated using a checkerboard 
assay to determine the ideal combined concentration to elicit either inhibitory or bactericidal 
effects.185  This technique is carried out by creating an array of all possible combinations of 
two antibiotics serially diluted within a desired range.200  The endpoint is typically evaluated 
at the lowest concentrations that inhibit growth (as determined by turbidity) and is expressed 
as the fractional inhibitory concentration (FIC) as determined from Equation 1.1:200,201 
 
AB BA
A B
MIC MICFIC
MIC MIC
= +         Eq. (1.1) 
 
where MICA and MICB are the inhibitory concentrations for the individual agents and MICAB 
and MICBA are the lowest combined concentrations to elicit an inhibitory effect.  The 
endpoint of the assay can be modified to require bactericidal activity, and can be combined 
with the principle of time-kill techniques200 to determine dose-dependency by evaluating 
viability as a function of time.107 
 
1.5 Summary of dissertation research 
My dissertation research has focused on the improvement and implementation of 
bioanalytical techniques to investigate non-specific bacterial adhesion and characterize the 
antimicrobial properties of NO.  The specific aims of my research included: 
 
1. the development of an improved AFM methodology for quantifying the lateral force 
required to detach bacteria adhered to a surface; 
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2. characterization of the kinetics of adhesion strength exhibited by P. aeruginosa and S. 
aureus to a hydrophobic xerogel coating in late stages of adhesion (> 18 h after 
attachment); 
3. the application of high-resolution AFM imaging to qualitatively visualize the 
morphological changes of two Gram-negative pathogens, E. coli and P. aeruginosa, 
after exposure to NO; 
4. determination of the concentration-dependent effects of NO released as a bolus from 
a small-molecule donor and time-dependent effects of NO released via a sustained 
surface flux from a xerogel coating using a quantitative analysis of membrane 
roughness; and 
5. the evaluation of the bactericidal efficacy elicited by NO and AgSD in combination 
against a wide range of pathogenic bacteria, including two antibiotic-resistant strains, 
using modified viability assays that require bactericidal efficacy within 2 h. 
 
The goal of this introduction (Chapter 1) was to provide background on the problem and 
process of infection as well as an overview of infection treatment in order to generate a 
context for understanding the motivation and potential applications of my dissertation 
research.  Chapter 2 introduces an improved technique for measuring the adhesion strength of 
bacteria and its application toward observing late-stage adhesion kinetics.  Chapter 3 
discusses the implementation of AFM to qualitatively observe changes in bacterial 
morphology after treatment with NO and compare with the effects of treatment with a cell 
wall-active agent, amoxicillin.  In addition, quantitative measurements of membrane 
roughness used to evaluate the dose-dependence of NO and compare two NO-delivery 
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methods are described.  Chapter 4 focuses on the use of stringent efficacy assays to 
determine the antimicrobial activity of NO and AgSD alone and in combination, while 
potential mechanisms to account for the observed synergistic activity are postulated.  Finally, 
Chapter 5 summarizes my dissertation research and suggests several interesting avenues for 
future research based upon both lateral force measurements acquired with AFM and the 
antimicrobial properties of NO. 
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Chapter 2: 
Quantitative method for determining the lateral strength of bacterial adhesion and 
application for characterizing adhesion kinetics 
 
2.1 Introduction 
Elucidation of the mechanisms of bacterial adhesion at surfaces is required to improve 
methods for preventing and treating implant-related infection.  As a necessary step in the 
pathogenesis of local infection, bacteria attach to the surface of medical devices and/or 
nearby host tissue.  The complicated mechanisms involved in bacterial adhesion to material 
surfaces have been reviewed previously.1-3  The type, number, and strength of the 
interactions involved in adhesion depend on multiple factors including microbial species,4,5 
surface properties,4,6-8 the presence of proteins or other conditioning layers on the surface,5,9-
12 experimental system parameters (e.g., temperature, exposure time and conditions),13,14 and 
the culture environment (e.g., growth phase, ionic strength, pH)2,4,15,16 under which adhesion 
occurred.   
The process of non-specific bacterial adhesion is often described as consisting of two 
distinct phases where initial, reversible physicochemical attachment precedes irreversible 
adhesion through molecular binding interactions (Section 1.1.3).17-20  In Phase I, the cell 
approaches the surface through a combination of mechanical processes (e.g., Brownian 
motion, gravity, motility structures) and long- and short-range reversible chemical 
interactions (e.g., electrostatic and hydrophobic interactions, and attractive van der Waals 
forces).  Once association has been established, the cell fortifies its attachment during Phase 
II via cellular and molecular interactions between macromolecules present on the exterior of 
the bacterium and the substratum in a complex and time-dependent process (>1-3 h).  The 
two phases of adhesion differ distinctly.  While Phase I involves interactions occurring away 
from and along vectors perpendicular to the surface and eventually leads to reversible 
attachment, Phase II is characterized by lateral reinforcement of adhesion through numerous 
irreversible binding interactions serving to establish a firm adherence of the cell to the 
underlying substrate after it reaches the surface.   
Two physical characteristics of bacterial adhesion, each related to either Phase I or Phase 
II, readily lend themselves to quantitative study: the affinity for association and the resistance 
to dissociation.  The proclivity of bacteria to interact and form associations with a surface is 
typically evaluated by determination of surface coverage of adhered cells.  While 
enumeration of surface-associated cells is more useful for understanding Phase I adhesion 
(where bacteria form a loose association with the surface), information on the lateral 
reinforcement or strength of adhesion that accompanies Phase II may be assessed by 
applying a measurable, physical force to dislodge the cells from the surface.  Lateral 
adhesion strength, studied by applying forces along a surface until the interactions are 
disrupted and the bacteria detach, is a measure of the friction force established between the 
cell and a surface due to a multitude of specific and non-specific chemical interactions.  
Previous studies have employed laminar flow21 and the application of an air-liquid interface 
via passage of air bubbles22 to dislodge bacteria attached to a surface and quantify lateral 
adhesion strength.  Both methods are limited by the inability to apply both controlled and 
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directed forces at a specific location.  Furthermore, the forces applied by laminar flow may 
be insufficient to detach all cells from the surface.21  
More recently, atomic force microscopy (AFM) has been used to apply forces with a 
probe while scanning in contact mode.23-25  Indeed, the ability to simultaneously detect the 
presence of single cells, apply a controlled and measurable force at a known location, and 
detect subsequent detachment of each adhered cell, all under pseudo-physiological conditions 
(i.e., in buffer) make AFM a useful tool for studying adhesion of living cells.  Atomic force 
microscopy has been used previously to evaluate the effect of surface 
roughness/topography23,25 and surface hydrophobicity24 on the strength of bacterial adhesion.  
These studies assumed a constant normal force between the probe and the underlying 
substrate (due to feedback loop adjustment) without determining the actual force applied by 
the probe to the cell at the time of its detachment.  Herein, we present a rigorous quantitative 
method for calculating the lateral strength of the adhesion of individual cells to a surface 
using AFM by determining the total cantilever compression (deflection) at each detachment 
event and accounting for probe geometry.   
While the kinetics of Phase I adhesion strength have been previously examined,26,27 a 
logical, and heretofore unexplored, application of AFM is the characterization of Phase II 
kinetics, the rate at which bacteria are capable of establishing lateral reinforcement and 
resistance to detachment.  The ability of cells to irreversibly enhance their stability against 
lateral or shear forces applied during relevant processes such as blood flow, the blinking of 
an eyelid, or wiping/scrubbing of a surface during a cleansing process are essential in their 
pathogenesis and the development of infections.  To this end, we apply the quantitative 
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method introduced to elucidate the kinetics of Phase II adhesion strength by observing the 
strength of adhesion as a function of time for P. aeruginosa and S. aureus.   
 
2.2 Experimental 
2.2.1 Materials.  Ethanol (absolute) was purchased from Fisher Scientific (Pittsburgh, 
PA).  N-(6-aminohexyl)aminopropyltrimethoxysilane (AHAP3) was obtained from Gelest 
(Tullytown, PA).  Isobutyltrimethoxysilane (BTMOS) was purchased from Aldrich (St. 
Louis, MO).  The amino- and alkoxysilanes were stored over dessicant.  The above 
chemicals were used without further purification.  Distilled water was purified with a 
Millipore Milli-Q UV Gradient A-10 system (Bedford, MA) to a resistivity of 18.2 MΩ*cm.  
P. aeruginosa (ATCC #19143) and S. aureus (ATCC #29213) were obtained from American 
Type Culture Collection (Manassas, VA). 
2.2.2 Substrate preparation.  Glass slides were coated with optically clear xerogel 
polymer films formed via sol-gel chemistry.  Briefly, a 40% (v:v total silane content) mixture 
of AHAP3/BTMOS was prepared via a 2-step process.28  First, 120 µl BTMOS was mixed 
with 60 µl water, 200 µl ethanol, and 10 µl of 0.5 M HCl for 1 h.  Then, 80 µl of AHAP3 was 
added, and the solution was mixed for an additional hour.  To cast a film, 40 µl of the 
polymer precursor solution was pipetted onto clean glass slides (dim. 13 x 17.5 mm) and 
allowed to dry at 85 °C for 3 d.  The xerogel-coated slides were stored in dessicators at room 
temperature until used.   
2.2.3 Cell culture.  P. aeruginosa and S. aureus were cultured separately at 37 °C in 
sterile tryptic soy broth (TSB) while shaking, centrifuged for 10 min at 4500 g, rinsed with 
ultrapure water, resuspended in 15% (v:v) glycerol, and stored as stock suspensions at -80 
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°C.  Bacterial cultures for daily use were grown from the -80 °C stock overnight at 37 °C.  
Next, 1 mL of overnight culture was inoculated in 100 mL of TSB and incubated at 37 °C for 
3-5 h until the culture reached a target optical density at 600 nm (OD600 ≈ 0.2 ± 0.1 for P. 
aeruginosa and OD600 ≈ 0.5 ± 0.1 for S. aureus) corresponding to mid-exponential log phase 
as determined by growth curves (data not shown).  
2.2.4 Substrate characterization.  Xerogel films have been used extensively in our 
laboratory to study bacterial adhesion28-30 and possess several suitable characteristics for 
AFM analysis of non-specific cell adhesion strength.  The xerogel coatings (40% (v:v) 
AHAP3/BTMOS) are hydrophobic (water contact angle ~90°).28,29  In addition, xerogel films 
resist the physical damage and deformation common to softer polymers.  AFM images of 
bare xerogels indicated a topologically featureless surface, providing a homogenous 
substratum for adherence.  The average RMS roughness of three separate regions of three 
independently prepared 40% (v:v) AHAP3/BTMOS xerogel films was 0.75 ± 0.47 nm over 
40 µm2 areas and 0.14 ± 0.02 nm over 1 µm2 areas.  The former is representative of the scan 
sizes evaluated for adhesion measurements while the latter represents surface roughness on 
the scale of a single bacterium. 
2.2.5 Bacterial adhesion.  Xerogel-coated substrates were rinsed with ultrapure water and 
ethanol, and dried under a stream of nitrogen.  A 200-µL aliquot of bacterial suspension in 
nutrient broth was pipetted directly onto the substrate and incubated at room temperature for 
1 h.  The substrate with adhered bacteria was immersed into a dish of PBS (pH = 7.4, Ic = 
0.16 M) for 3 h, rinsed with ultrapure water, and dried under a gentle stream of nitrogen.  The 
surface coverage of cells on the substrate was determined by imaging representative 40 µm2 
regions of the surface using contact mode AFM.  After 1 h in ambient air, the substrate was 
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placed into a fresh PBS solution at room temperature until analysis.  The short drying step, 
modeling the type of cellular transfer that might occur prior to in vivo implantation of a 
medical device, proved necessary to initiate firmly-adhered cells. 
2.2.6 CFU viability count.  To determine the viability of adhered cells under experimental 
conditions, prepared substrates were briefly sonicated for 5 min in PBS, and rinsed with an 
additional 5 mL of PBS to remove cells loosened, but not detached, by sonication.  Serial 
dilutions of the sonicant were prepared, 100-µL aliquots spread onto nutrient agar plates, and 
incubated at 37 °C overnight.  Observed colonies were then counted.  The total number of 
viable cells removed from the substrate was back-calculated. 
2.2.7 AFM imaging.  Simultaneous AFM height, deflection, and lateral images were 
obtained in contact mode using an Asylum MFP-3D atomic force microscope (Santa 
Barbara, CA) with manufacturer provided software.  Silicon nitride (Si3N4) triangle-shaped 
cantilevers with nominal spring constants of 0.06, 0.12, and 0.32 N/m were used to obtain 
images and measure forces (DNP-S, Veeco, Santa Barbara, CA).  Root mean square (RMS) 
measurements of xerogel surface roughness were obtained in air using the most rigid 
cantilever.  Images for force measurement were acquired in PBS at a scan rate of 1 Hz and 
scan size of 40 µm2 with a 512 x 512 line/pixel resolution.  The scan size and resolution were 
optimized to collect data from multiple cells during a single run while maintaining sufficient 
resolution to observe single cells for positive identification and force determination (e.g., ~10 
pixels across the width of the cell). 
2.2.8 Force calculation.  The tip-surface force applied by an AFM probe to the 
underlying substrate during scanning was calculated using Hooke’s Law, Fz = k d, where the 
cantilever is approximated as a spring with an associated spring constant, k, and is 
 65
compressed (deflected) by a distance, d, as it interacts with the surface during scanning (Fig. 
2.1A).  Direct application of Hooke’s Law gives the applied force normal to the compression 
of the spring, which in the case of AFM is the force applied by the tip of the probe.  
However, when the probe interacts with a large feature such as a bacterium, the point of 
interaction moves from the tip to the side of the probe, and the applied force normal to the 
plane of interaction is calculated from Equation 2.1  
 
Fapp = k d sin (θ + Φ)                        Eq. (2.1) 
 
where the angles θ and Φ are parameters of the probe geometry and cantilever orientation, 
respectively (Fig. 2.1B).  The lateral component (Flat) of the applied force (Fapp) is 
responsible for applying the shear force to detach adhered cells and is determined using 
Equation 2.2 
 
Flat = Fapp cos (θ).         Eq. (2.2) 
 
The cantilever deflection, d, for any point in an image was determined by d = ∆V S-1, 
where the total change in the output signal due to vertical movement of the laser on the 
photodiode detector resulting from compression, ∆V, is multiplied by the inverse optical 
lever sensitivity (S-1), a calibration factor relating the deflection-detector sensitivity.  The 
inverse optical lever sensitivity (S-1), the value of the slope in the constant compliance region 
of a force curve (deflection (nm) versus output signal (V)), was determined before each 
experiment using a clean mica substrate. 
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Figure 2.1  (A)  The vertical and lateral components of the normal force applied by an AFM 
probe to an adhered cell are illustrated schematically.  The latter component is responsible 
for applying the lateral force to detach cells, and is directly related to the normal force by the 
angle θ.  (B)  By modeling the slightly compressed cantilever as a straight line, a direct 
relationship can be drawn between Φ, which varies with the distance of compression, and θ. 
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2.2.9 Kinetic assay.  A kinetic assay was designed to identify a time frame of dynamic 
change in adhesion strength.  An initial image of adhered bacteria was obtained in contact 
mode in PBS at a setpoint (user-defined change in output signal maintained by the feedback 
loop through cantilever compression and corresponding to an approximate tip-surface force) 
near the limit of detection.  For our system, the limit of detection was approximately 0.2 nN 
with k = 0.06 N/m.  Of note, the limit of detection will vary directly with k and S-1 and is a 
function of detector sensitivity.  The imaged cells were counted to establish the baseline 
number of total cells detected.  The ability of these cells to withstand scanning at higher tip-
surface forces (Fz) was tested by adjusting the setpoint to predetermined low and high Fz of 
2.5 nN and 15 nN, respectively, and rescanning the same region at each threshold.  The 
percentage of cells able to withstand detachment at each threshold was then determined.  The 
assay was repeated at different regions of the substrate every 6 h for 48 h after exposure of 
the substrate to the bacterial suspension. 
2.2.10 Measurement of adhesion kinetics.  To observe detailed changes in bacterial 
adhesion strength, an analogous process of acquiring consecutive images over a region was 
employed.  In contrast to the kinetic assay, however, the actual lateral force applied to each 
individual bacterium at the time of detachment was determined.  As before, an initial image 
was obtained at a low setpoint (~ 5 nN) to establish the number of cells present within a 40 
µm2 scan region.  This starting threshold force was empirically determined for our system 
(e.g., adhesion conditions, substrate) to select for securely adhered bacteria representative of 
Phase II bacterial adhesion, while removing loosely attached cells.  Of note, scanning at 
lower tip-surface forces did not yield significantly more cells.  The setpoint was increased 
incrementally for subsequent scans so that increasingly higher forces were applied until all 
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cells in the scan region were removed.  No cell was imaged in subsequent scans that did not 
appear in the first scan.  After displacement, cells likely become planktonic, at least briefly, 
as the imaging artifacts observed (i.e., streaks) clearly indicate that rolling or pushing of cells 
does not extend to the periphery of the scan.  After all cells in a scan region were displaced, 
the probe was systematically moved to a different location on the substrate several 
millimeters away from the previous analysis area, and the process was repeated. 
  To calculate the force applied for removal of a cell, the set of height and deflection 
scans consisting of a run was visually examined to identify the image in which each cell was 
last detected (partially imaged cell) (Fig. 2.2A-C).  Cell removal was indicated by greater 
error in setpoint deflection relative to previous line scans and was occasionally accompanied 
by a streaking artifact.  Such streaks originate from temporary continued association of the 
cell with the tip as the cell moves away from the location of its attachment.  The error in 
setpoint deflection is easily visualized in the deflection image, and the force responsible for 
bacterial detachment likely originates from an accumulation of cantilever bending prior to 
feedback loop correction (Fig. 2.2D-E).  Thus, the line where detachment occurred was 
identified for each bacterium.  The total compression of the cantilever at the time of 
detachment was calculated by summing the distance of compression required to obtain the 
setpoint from the free air deflection (i.e., position of the laser on the photodiode before the 
probe contacts the surface) with the additional error from the setpoint at detachment (Fig. 
2.3).  Upon determining the total cantilever compression responsible for cell detachment on 
an individual basis and the geometrical analysis of the system, Flat was calculated 
independently for each bacterium, using Eq. 2.2. 
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Figure 2.2  In three consecutive AFM scans, S. aureus cells are imaged at ∆Vsetpoint of (A) 
0.80 V, (B) 1.35 V, and (C) 3.00 V.  The partially imaged cell highlighted in (B) is an 
example of a bacterium undergoing detachment.  This cell is imaged completely in (A) and is 
no longer visible in (C).  The scale bar indicates error from setpoint deflection, where 
increased cantilever compression corresponds to positive values.  (D-E) From the deflection 
values of the scan line where the cell detaches, the change in deflection (∆d) is determined, 
which is directly related to ∆Vdeflection error by a factor of S-1.  ∆d is calculated as the difference 
between the baseline (setpoint) deflection and the peak in deflection error (indicated by the 
round cursor) and can be converted to the additional force applied by cantilever compression 
beyond the setpoint. 
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Figure 2.3  The laser position on the position sensitive diode (PSD) changes in response to 
cantilever compression.  Position 1 represents the laser position at free air deflection.  When 
the tip engages with the surface, the cantilever is compressed to the setpoint (position 2) and 
the total change in output signal is ∆Vsetpoint.  During scanning when the probe encounters a 
raised feature, the cantilever is compressed past the setpoint.  This additional compression is 
termed deflection error and is illustrated as the change in output signal, ∆Vdeflection error, 
between position 2 and 3 on the PSD.  The total compression of the cantilever, deflecting the 
laser from position 1 to 3, is used to determine the force applied at detachment.
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2.3 Results  
2.3.1 Long-term observation of adhesion kinetics.  A kinetic assay of bacterial adhesion 
strength was utilized to monitor the adhesion dynamics of P. aeruginosa in PBS over 2 d.  
First introduced by Boyd et al.,23 the technique involves determining the number of cells 
capable of withstanding probe interaction at pre-set vertical tip-surface forces (setpoints).  
However, neither the lateral component of the applied force nor the applied force for 
individual cell removal based on total cantilever compression was determined.  Instead, all 
cells remaining after scanning at a particular setpoint (Fz) were assigned an empirical 
threshold adhesive force related to the setpoint.  This simple assay allowed efficient 
observation of increasing adhesion strength trends over time and was useful in identifying a 
time window of interest for in-depth kinetic studies.  Nevertheless, it does lack the accuracy 
of the more time-consuming method based on determining the total cantilever compression at 
the time of detachment (used later in our study). 
The percentages of surface-adhered P. aeruginosa cells that withstood probe interaction 
at both low and high threshold probe-surface forces as a function of time are shown in Figure 
2.4.  At 18 h after initial adhesion, two significant and related observations were made.  The 
percentage of cells with adhesion strength greater than the lateral force applied by a setpoint 
of 2.5 nN began to increase at an accelerated rate.  Furthermore, some cells had generated 
sufficient adhesion strength to withstand a six-fold greater scanning force (i.e., 15 nN).  
Between 18 and 42 h, the percentage of cells remaining attached continued to increase, with 
the most drastic rise occurring 24–30 h after exposure, where the amount of cells remaining 
adhered was approximately six- fold higher than that achieved in the 6 h period immediately 
prior.  The percentage of cells capable of withstanding 15 nN of tip-surface force increased  
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Figure 2.4  The percentage of P. aeruginosa cells which remain adhered to the substrate 
after scanning the surface at threshold tip-surface setpoint forces of 2.5 (■) and 15 nN (●). 
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~ four-fold during the same 6 h time window compared to the previous period (14.3% and 
3.3%, respectively).  Based on these observations, the most notable adhesion dynamics 
occurred over an 8 h period.   
2.3.2 Quantitative measurement of adhesion kinetics.  The quantitative method for 
determining the strength of bacterial adhesion was used to study the adhesion strengths of 
individual adhered P. aeruginosa and S. aureus cells over similar periods to compare the 
non-specific adhesion of two distinct pathogenic strains of bacteria.  The experiments were 
conducted from different cultures in triplicate for each species.  The average lateral force 
required to remove all cells within a scan region is shown in Figure 2.5.  As the majority of 
cells detected were typically removed during the first half of the run, the points in the graph 
representing the average force for a region correspond to the length of time after exposure 
associated with the lowest setpoint scan.  The overall magnitude of forces required to detach 
P. aeruginosa (Fig. 2.5A) was significantly greater than for S. aureus (Fig. 2.5B).  In fact, the 
cantilevers were no longer capable of applying sufficient force to remove every P. 
aeruginosa cell from the xerogel substrate after ~26 h.  Table 2.1 lists both the average 
adhesion strength rates measured for independent experiments and the overall average and 
standard deviation for each species.  The average rate of adhesion strength increase was 
almost seven-fold faster for P. aeruginosa (3.36 ± 0.08 nN/h) than for S. aureus (0.50 ± 0.09 
nN/h).  
Figure 2.6A shows the average lateral forces necessary to detach S. aureus in a single 
experiment.  Examination of the component measurements used in calculating these average 
forces revealed two additional trends in adhesion kinetics that could not be resolved from the  
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Figure 2.5  The average lateral force required for cell detachment measured for each (A) P. 
aeruginosa (▼) and (B) S. aureus (■) cell within a scan region between 19 and 27 h after 
substrate exposure to cell suspension.  The error bars indicate the standard error over all 
measurements taken with a scan area.  Data points obtained during duplicate and triplicate 
experiments are indicated by the open and cross-hatched symbols, respectively. 
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Table 2.1 Average, basal and elite adhesion rates for P. aeruginosa 19 – 26 h after initial 
adhesion and S. aureus 19 – 28 h after initial adhesion from three independent kinetics 
experiments per species.  After 26 h, the cantilevers used in this study were no longer able to 
apply sufficient lateral force to detach all P. aeruginosa cells from the substrate. 
 
 
 
species average (nN/h) basal (nN/h) elite (nN/h) 
P. aeruginosa 3.36 ± 0.08 0.0 ± 0.2 9 ± 1 
S. aureus 0.50 ± 0.09 0.17 ± 0.09 1.4 ± 0.4 
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Figure 2.6  (A) The average force of detachment measured for S. aureus per scan region (■) 
as a function of time for a single experiment.  The error bars indicate the standard error of all 
measurements taken within the scan region.  (B) The average force of detachment measured 
for S. aureus per scan in the same experiment at the following timepoints:  19 h (), 20 h 
(¢), 21 h (●), 22 h (+), 24 h (x), 25 h (Â), and 26 h ().  The error bars indicate the standard 
deviation over all measurements taken with a single scan. 
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average values alone.  By breaking down the average lateral forces measured in each scan 
region during an entire run into adhesion measurement averages for each scan (Fig. 2.6B), a 
large range of detachment forces were evident in each region.  Furthermore, the range of 
forces broadened with time.  Though example data is provided for a single S. aureus 
experiment, similar trends were observed for all other experiments involving both species of 
bacteria.  The trends indicate that adhesion strength increases vary with bacteria species.   
A population of cells whose detachment occurs in the first scan of each run was always 
apparent.  In contrast, another population of cells, the last to be removed from each scan area, 
became increasingly more difficult to detach over time.  Examining only those cells that were 
detached in the first and last scan of each run in relation to the average over the entire region 
(Fig. 2.7) allowed for the deterimination of adhesion kinetics for “basal” and “elite” cell 
populations, respectively (Table 2.1).  The elite S. aureus population was characterized 
having a ten-fold larger rate of adhesion over the basal cells (1.4 ± 0.4 nN/h and 0.17 ± 0.09 
nN/h, respectively).  The basal P. aeruginosa population exhibited no appreciable increase in 
adhesion rate (0.0 ± 0.2 nN/h), while the adhesion strength kinetics of the elite population 
increased at 9 ± 1 nN/h, a value significantly greater than that observed for elite S. aureus.  
Additional plots of basal and elite P. aeruginosa and S. aureus populations are provided in 
Figure 2.8.  
2.3.3 Intercellular interactions.  To evaluate the effect of cell-cell interactions on force 
measurements, standard statistical analysis was employed.  Only S. aureus were examined as 
such cells have a tendency to grow and adhere in clusters.  In contrast, P. aeruginosa cells 
were observed to adhere more typically as single cells.  Forces in a particular run were 
grouped as either clustered or independent, and an Anova single-factor analysis was  
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Figure 2.7  Adhesion kinetics from a single experiment for (A) S. aureus basal (♦), average 
(■), and elite (S) population of cells and (B) P. aeruginosa basal (¢), average (▼), and elite 
(●) cell populations. 
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Figure 2.8  Average measured (A) basal and (B) elite detachment forces for replicate P. 
aeruginosa experiments.  Average measured (C) basal and (D) elite detachment forces for 
replicate S. aureus experiments. 
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conducted.  Cells with a neighbor oriented perpendicular to the applied lateral force were 
evaluated separately from those with a neighbor oriented in line with the direction of probe 
movement.  No statistical difference in force measurements existed between independent 
cells and those in close proximity to neighboring cells.  At least three runs encompassing 
both high and low setpoints were evaluated for each neighbor orientation. 
2.3.4 Cell viability.  The viability of P. aeruginosa and S. aureus was evaluated after 30 h 
resident adhesion time by sonication of the colonized surfaces, and subsequent plating and 
growth on agar nutrient medium.  The number of viable cells removed per surface area was 
calculated from the number of colonies observed after overnight incubation at 37 °C (Table 
2.2).  The numbers of viable colonies observed were in close agreement with the average 
number of cells detected during an experimental run. 
 
2.4 Discussion 
The primary aim of our studies was to develop an improved method for more accurately 
measuring and comparing the strength of adhesion of bacterial cells in situ via AFM.  By 
employing a geometrical analysis of the applied force vectors coupled with quantification of 
the total cantilever compression responsible for applying the detachment force for each 
individual cell, the lateral force (Flat) necessary to overcome the force of adhesion was 
determined on a per cell basis.  The method is broadly applicable to any number of species, 
substrates, and preparation procedures.  Upon evaluating changes in bacterial adhesion 
strength as a function of time, a number of interesting observations became evident. 
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Table 2.2   Comparison of the number of viable cells recovered after 30 h adherence in PBS 
to the average number of cells detected using AFM.  The number of cfu counted was back-
calculated to determine the average number of viable cells recovered from a 40 µm2 region of 
the substrate. 
 
 
 
 
species viable cells recovereda cells detecteda
P. aeruginosa 14.4 14.6 ± 7.5 
S. aureus 35.5 32.2 ± 20.0 
 
aper 40 µm2 surface area of the substrate 
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2.4.1 Variation in interspecies kinetics.  Regardless of the time adhered to our model 
substrate, the adhesion of P. aeruginosa was significantly greater relative to S. aureus.  
Assessing the differences in cell-surface properties that exist between the two species may be 
helpful in understanding the gap in measured adhesion strength.  Both the size and shape of 
the bacteria differ significantly.  P. aeruginosa is a rod-shaped bacterium (1 x ~3 µm) while 
S. aureus is spherically shaped (d ~ 1 µm).  Larger, rod-shaped bacteria would be expected to 
contact the substrate to a greater extent due to their size and degree of curvature.  Gomez-
Suarez et al. also reported superior adhesion of rod-shaped bacteria over coccal species upon 
exposure to low-velocity air bubbles.22   
Another likely contributing factor for the differences in adhesion strength may stem from 
the intrinsic flexibility, or lack thereof, inherent in the varying component layers of the cell 
wall.  The gram-positive cell wall is coated with a thick peptidoglycan layer that is rigid in 
nature.  In contrast, the gram-negative cell wall is characterized by a thinner layer of 
peptidoglycan matrix surrounded by a flexible outer phospholipid bilayer.  Thus, not only is 
P. aeruginosa capable of establishing a larger footprint of contact, but its added flexibility 
allows additional freedom to conform or expand against the substrate to further increase its 
surface area of interaction.  The effect of flexibility on increasing surface contact area has 
been observed previously for Bacillus mycoides spores on a similarly modified glass 
substrate.31  
In addition to cell morphology, the polymeric and proteinaceous structures present on the 
exterior of the cell differ between species and strains.  In general, it is difficult to predict the 
mediating effect of these variations on non-specific attachment, but recent studies have 
shown increasing adhesion forces over short surface-resident time periods (~100 s) between 
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colloids and protein coated surfaces.32,33  Additionally, greater surface contact between 
features of the cell and the substrate presumably lead to an increase in the number of 
potential interactions (e.g., van der Waals interactions) that may be established to reinforce 
adhesion strength.  While the contribution to adhesion of each individual non-covalent bond 
is small, the combined effect generates an essentially irreversible attachment.  A number of 
studies point to the roles of proteins and polysaccharides at the exterior of the cell on 
bacterial adhesion.34,35  In addition to having filimentous proteinaceous features termed 
fimbriae, or pili, P. aeruginosa is known to produce an alginate extracellular polysaccharide 
slime (glycocalyx) that facilitate both non-specific and specific adhesion.  Likewise, S. 
aureus produces a microcapsule that with other external components, such as lipoteicoic acid 
and a variety of specific protein receptors plays a role in the adhesive mechanisms of the 
species.36  The importance of surface-adsorbed matrix proteins such as fibrinogen and 
fibronectin for promoting S. aureus colonization of biomaterial surfaces has been reported 
previously and may partially explain the lower measured adhesive forces observed for S. 
aureus relative to P. aeruginosa using bare biomaterial substrates.37-40  
2.4.2 Intraspecies population kinetics.  As evidenced by our data, not all cells of the same 
species and culture are equally capable of establishing the ability to withstand detachment 
from the same surface.  Dickenson and Cooper observed a similar phenomenon while 
studying the detachment rate of S. aureus adhered to different polymeric surfaces in a 
laminar flow field as a function of shear stress.41  They reported that cell attachment followed 
first-order rate kinetics.  However, the detachment rate of adhered cells at early periods was 
more rapid, slowing with time.  The range of shear stresses used in their experiments was 
insufficient to remove all cells adhered to the substrates.  These results correspond with our 
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observation that most cells were detached when subjected to low tip-cell forces, while a 
certain population of cells required much larger applied forces to initiate cell detachment.  
Dickenson and Cooper proposed that a homogeneous cell population exhibiting a 
heterogeneous adhesion energy distribution may result from a combination of the small 
surface contact area established by each cell and the variation in molecular components 
existing in this contact region.  Other researchers have reported similar heterogeneity in the 
detachment of receptor-coated beads that model cells.41-43  
The wide range of adhesion forces measured for cell detachment may also be attributed to 
the complex combinations of changes in metabolic processes resulting from surface adhesion 
or proximate cell signaling.  Sauer et al. described a number of changes in gene regulation for 
P. aeruginosa at discrete stages of biofilm development following initial attachment, 
including 57 specific proteins expressed in cell populations at the irreversible attachment 
stage (Phase II) that were absent or weakly detected in planktonic cells.44  While some of the 
changes in gene regulation were linked directly to quorum sensing, the authors suggested 
additional surface-induced expression of proteins that might play a role in increasing 
adhesion strength after initial attachment.  The heterogeneity in adhesion strength observed 
in this study may be an observation of such physiological changes that occur after bacteria 
attach to a surface. 
Local variations in substrate properties may also influence bacterial adhesion.  Deviations 
from theoretical predictions of adhesion behavior have previously been attributed to 
heterogeneity in surface properties.  Using AFM force-mapping, Vadillo-Rodríguez et al. 
reported the presence of a small number of randomly distributed high-adhesion sites on silica 
and metal oxide surfaces.45  The model surfaces used in our study were partially composed of 
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aminosilanes whose amines are protonated at physiological pH.  While we assumed that 
these charges were distributed across the surface due to repulsive interaction, it is possible 
that higher densities of aminosilanes may exist locally.  Bacteria with negatively charged 
functional groups present on the exterior of the membrane would be attracted to such regions.  
Such interactions would likely yield greater adhesion to the surface over time due to 
increased water exclusion and hydrophobic interactions. 
2.4.3 Quantitative force determination.  The premise of previous reports relies on the 
principle that when imaging a surface in contact mode, the applied force between the probe 
and substrate is held constant by a feedback loop.  Thus, empirical relationships were drawn 
between the tip-surface setpoint force maintained by the feedback loop of the AFM and the 
number of cells withstanding imaging at such applied forces to evaluate bacterial adhesion 
strength.23-25  While this method has merit for preliminary studies of bacterial adhesion 
kinetics, we believe it is not adequate for quantitative determination of the actual force that is 
applied at cell detachment.  Rather, the feedback loop response occurs after a finite time.  
When a large feature such as a cell is encountered, an instantaneous increase in cantilever 
deflection is unavoidable.  This phenomenon may be observed in real time and collected as 
an image by directing an AFM channel to record the difference between setpoint deflection 
and actual deflection (i.e., deflection error) for each point corresponding with the height 
image.  The effect is exacerbated by using cantilevers with low spring constants and low 
setpoints where additional force due to deflection error contributes a significant percentage of 
the overall force applied to the cell by the probe.  By examining the total force applied to all 
cells removed at representative low (0.10 V) and high (5.00 V) setpoint scans (Table 2.3), the 
contribution to normal force calculation from deflection error becomes evident.  Without  
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Table 2.3  Comparison of the actual normal force applied to the cell and the tip-surface force 
adjusted for by the feedback loop for both small and large setpoints. 
 
 
 
 
 
setpoint 
(V) 
deflection 
error  
(nm) 
total 
compression 
(nm) 
normal 
forcea  
(nN) 
setpoint 
forcea
(nN) 
percent 
errorb  
(nN) 
0.100 24.1 106 12.8 9.32 -27.2 
0.100 24.8 107 12.9 9.32 -27.8 
0.100 41.7 127 15.3 9.32 -39.1 
      
5.00 15.0 706 84.7 82.5 -2.60 
5.00 35.1 730 87.6 82.5 -5.82 
 
aNominal spring constant = 0.12 N/m 
bPercent error from the normal force (calculated from the total compression of the cantilever) 
obtained by using the setpoint force  
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correcting for setpoint deflection error, the values calculated for the applied forces within 
each scan would all be equivalent and systematically underrepresented. 
While determining total cantilever compression was a key improvement to the method 
introduced herein, other modifications were made in force measurement and data acquisition 
procedures to further improve accuracy of bacterial adhesion strength values.  First, the free 
air deflection of the probe was measured before and after each scan to account for thermal 
drift.  Large areas (40 µm2) were scanned to observe the adhesion strength of many cells (~10 
to 50) simultaneously, improving the statistical significance of the data generated.  In 
addition, proper orientation of the cantilever and tip during imaging scans was maintained.  
Only deflection data accumulated from the ‘retrace’ (i.e., movement of the probe from tip 
end along the long axis of the cantilever toward the cantilever holder) was used in acquiring 
force measurements.  If scanning along the long axis in the opposite direction, buckling of 
the cantilever may occur.  Changes in the output signal due to buckling would be 
indistinguishable from those resulting from bending.  In contrast, scanning laterally (along 
the short axis of the cantilever) torsional force is applied by twisting in the cantilever due to 
tip-cell interactions twist the cantilever.  Buckling and twisting of the cantilever deviate from 
the spring model and Hooke’s Law.   
In addition to assuring that our force application system can be approximated by Hooke’s 
Law, it is much more relevant to determine and report the actual force responsible for 
detachment (Flat) versus the applied force (Fapp) or setpoint force (Fz).  By approximating the 
slightly bent cantilever as a straight line, geometrical analysis showed that the directional 
change of the normal force applied by a pyramidal probe at a known tilt was not significant 
over the range of cantilever compression used in this study (Fig. 2.2B, Appendix).  As such, 
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the lateral forces reported herein were calculated using the known tilt of the cantilever and 
geometry of the AFM probe. 
 
2.5 Conclusions 
A quantitative method for measuring the strength of bacterial adhesion was described 
enabling the discrimination of adhesion forces measured by AFM at a single setpoint by 
determining total cantilever compression from deflection error image analysis.  Compared to 
previous methods, this method allowed for more accurate measurement of the actual normal 
and lateral force applied to bacteria while imaging in contact mode.  We thus describe a 
useful tool for characterizing changes in non-specific adhesion strength of bacteria that may 
be easily applied to evaluating the effect of a number of variables including protein 
mediation and substrate properties on bacterial adhesion. 
Analysis of adhesion forces measured for P. aeruginosa and S. aureus as a function of 
time indicated that the strength of bacterial adhesion is both dynamic and non-uniform for 
both species.  P. aeruginosa demonstrated significantly greater overall adhesion forces and 
rates of increasing adhesion strength than S. aureus.  The size, shape, and cell wall structure 
of P. aeruginosa contribute to its superior ability to adhere non-specifically to a substrate.  
The apparent heterogeneity in the adhesion of cells of the same species under similar 
conditions may be attributed to variation in the states of adhesion energy attained, local 
variation in surface characteristics, and/or metabolic changes in gene regulation after surface 
attachment.   
 
 89
2.6  References 
 
(1) An, Y. H.; Friedman, R. J. Concise review of mechanisms of bacterial adhesion to 
biomaterial surfaces. J. Biomed. Mater. Res. (Appl. Biomater.) 1998, 43, 338-348. 
(2) Dankert, J.; Hogt, A. H.; Feijen, J. Biomedical polymers: Bacterial adhesion, 
colonization, and infection. CRC Crit. Rev. Biocompat. 1986, 2, 219-301. 
(3) Katsikogianni, M.; Missirlis, Y. F. Concise review of mechanisms of bacterial 
adhesion to biomaterials and of techniques used in estimating bacteria-material 
interactions. Eur. Cells Mater. 2004, 8, 37-57. 
(4) Li, B.; Logan, B. E. Bacterial adhesion to glass and metal-oxide surfaces. Colloids 
Surf., B 2004, 36, 81-90. 
(5) Hogt, A. H.; Dankert, J.; Feijen, J. Adhesion of Staphylococcus epidermidis and 
Staphylococcus saprophyticus to a hydrophobic biomaterial. J. Gen. Microbiol. 1985, 
131, 2485-2491. 
(6) Dickinson, R. B.; Nagel, J. A.; Proctor, R. A.; Cooper, S. L. Quantitative comparison 
of shear-dependent Staphylococcus aureus adhesion to three polyurethane ionomer 
analogs with distinct surface properties. J. Biomed. Mater. Res. 1997, 36, 152-162. 
(7) Chin, M. Y. H.; Sandham, A.; Pratten, J.; de Vries, J.; van der Mei, H. C. et al. 
Multivariate analysis of surface physico-chemical properties controlling biofilm 
formation on orthodontic adhesives prior to and after fluoride and chlorhexidine 
treatment. J. Biomed. Mater. Res. (Appl. Biomater.) 2006, 78B, 401-408. 
(8) Tang, H.; Cao, T.; Wang, A.; Liang, X.; Salley, S. O. et al. Effect of surface 
modification of siliconeon to Staphylococcus epidermidis adhesion and colonization. 
J. Biomed. Mater. Res. 2006, 80A, 885-894. 
(9) Dickinson, R. B.; Nagel, J. A.; McDevitt, D.; Foster, T. J.; Proctor, R. A. et al. 
Quantitative comparison of clumping factor- and coagulase-mediated Staphylococcus 
aureus adhesion to surface-bound fibrinogen under flow. Infect. Immun. 1995, 63, 
3143-3150. 
(10) Kussela, P. Fibronectin binds to Staphylococcus aureus. Nature 1978, 276, 718-720. 
(11) Morris, E. J.; McBride, B. C. Adherence of Streptococcus sanguis to saliva-coated 
hydroxyapatite: Evidence for two binding sites. Infect. Immunol. 1984, 43, 656-663. 
 90
(12) Paulsson, M.; Kober, M.; Freij-Larsson, C.; Stollenwerk, M.; Wesslen, B. et al. 
Adhesion of Staphylococci to chemically modified and native polymers, and the 
influence of preadsorbed fibronectin, vitronectin and fibrinogen. Biomaterials 1993, 
14, 845-853. 
(13) Orstavik, D. Sorption of Streptococcus faecium to glass. Acta Pathol. Microbiol. 
Scand. 1977, 85B, 38-46. 
(14) Dudderiege, J. E.; Cent, C. A.; Laws, J. E. Effect of surface shear stress on the 
attachment of Pseudomonas fluorescens to stainless steel under defined flow 
conditions. Biotechnol. Bioeng. 1982, 24, 153-164. 
(15) McWhirter, M. J.; McQullan, A. J.; Bremer, P. J. Influence of ionic strength and pH 
on the first 60 min of Pseudomonas aeruginosa attachment to ZnSe and to TiO2 
monitored by ATR-IR spectroscopy. Colloids Surf., B 2002, 26, 365-372. 
(16) Walker, S. L.; Redman, J. A.; Elimelech, M. Influence of growth phase on bacterial 
deposition: Interaction mechanisms in packed-bed column and radial stagnation point 
flow systems. Environ. Sci. Technol. 2005, 39, 6405-6411. 
(17) An, Y. H.; Dickinson, R. B.; Doyle, R. J. Mechanisms of Bacterial Adhesion and 
Pathogenesis of Implant and Tissue Infections. Handbook of Bacterial Adhesion: 
Principles, Methods, and Applications; Humana Press Inc.: Totowa, NJ, 2000; pp 1-
27. 
(18) Gristina, A. G. Biomaterial-centered infection: Microbial adhesion versus tissue 
integration. Science 1987, 237, 1588-1595. 
(19) Marshall, K. C. Mechanisms of bacterial adhesion at solid-water interfaces. Bacterial 
adhesion: mechanisms and physiological significance; Plenum Press: New York, 
1985; pp 133-161. 
(20) Vacheethasanee, K.; Marchant, R. E. Nonspecific Staphylococcus epidermidis 
Adhesion: Contributions of Biomaterial Hydrophobicity and Charge. Handbook of 
Bacterial Adhesion; Humana Press: Totowa, NJ, 2000; pp 73-90. 
(21) Dickinson, R. B.; Cooper, S. L. Analysis of shear-dependent bacterial adhesion 
kinetics to biomaterial surfaces. AIChE J. 1995, 41, 2160-2174. 
(22) Gomez-Suarez, C.; Busscher, H. J.; van der Mei, H. C. Analysis of bacterial 
detachment from substratum surfaces by the passage of air-liquid interfaces. Appl. 
Environ. Microbiol. 2001, 67, 2531-2537. 
 91
(23) Boyd, R. D.; Verran, J. Use of the atomic force microscope to determine the effect of 
substratum surface topography on bacterial adhesion. Langmuir 2002, 18, 2343-2346. 
(24) Senechal, A.; Carrigan, S. D.; Tabrizian, M. Probing surface adhesion forces of 
Enterococcus faecalis to medical-grade polymers using atomic force microscopy. 
Langmuir 2004, 20, 4172-4177. 
(25) Whitehead, K. A.; Rogers, D.; Colligon, J.; Wright, C.; Verran, J. Use of the atomic 
force microscope to determine the effect of substratum surface topography on the 
ease of bacterial removal. Colloids Surf., B 2006, 51, 44-53. 
(26) Meinders, J. M.; van der Mei, H. C.; Busscher, H. J. Physicochemical aspects of 
deposition of Streptococcus thermophilus B to hydrophobic and hydrophilic substrata 
in a parallel plate flow chamber. J. Colloid Interface Sci. 1994, 164, 355-363. 
(27) Vadillo-Rodríguez, V.; Busscher, H. J.; Norde, W.; de Vries, J.; van der Mei, H. C. 
Atomic force microscopic corroboration of bond aging for adhesion of Streptococcus 
thermophilus to solid substrata. J. Colloid Interface Sci. 2004, 278, 251-254. 
(28) Marxer, S. M.; Rothrock, A. R.; Nablo, B. J.; Robbins, M. E.; Schoenfisch, M. H. 
Preparation of nitric oxide (NO)-releasing sol-gels for biomaterial applications. 
Chem. Mater. 2003, 15, 4193-4199. 
(29) Nablo, B. J.; Schoenfisch, M. H. Antibacterial properties of nitric oxide-releasing sol-
gels. J. Biomed. Mater. Res. 2003, 67A, 1276-1283. 
(30) Hetrick, E. M.; Schoenfisch, M. H. Antibacterial nitric oxide-releasing xerogels: Cell 
vialility and parallel plate flow cell adhesion studies. Biomaterials 2007, 28, 1948-
1956. 
(31) Bowen, W. R.; Fenton, A. S.; Lovitt, R. W.; Wright, C. J. The measurement of 
Bacillus mycoides spore adhesion using atomic force microscopy, simple counting 
methods, and a spinning disk technique. Biotechnol. Bioeng. 2001, 79, 170-179. 
(32) Xu, L.; Logan, B. E. Interaction forces measured using AFM between colloids and 
surfaces coated with both dextran and protein. Langmuir 2006, 22, 4720-4727. 
(33) Xu, L.; Logan, B. E. Adhesion forces between functionalized latex microspheres and 
protein-coated surfaces evaluated using colloid probe atomic force microscopy. 
Colloids Surf., B 2006, 48, 84-94. 
 92
(34) Kwon, K. D.; Vadillo-Rodriguez, V.; Logan, B. E.; Kubicki, J. D. Interactions of 
biopolymers with silica surfaces: Force measurements and electronic structure 
calculation studies. Geochim. Cosmochim. Acta 2006, 70, 3803-3819. 
(35) Xu, L.; Logan, B. E. Interaction forces between colloids and protein-coated surfaces 
measured using an atomic force microscope. Environ. Sci. Technol. 2005, 39, 3592-
3600. 
(36) Montanaro, L.; Arciola, C. R. Studying Bacterial Adhesion to Irregular or Porous 
Surfaces. Handbook of Bacterial Adhesion: Principles, Methods, and Applications; 
Humana Press Inc.: Totowa, NJ, 2000; pp 331-343. 
(37) Cheung, A. L.; Fischetti, V. A. The role of fibrinogen in Staphylococcal adherence to 
catheters in vitro. J. Infect. Dis. 1990, 161, 1177-1186. 
(38) Hermann, M.; Vaudaux, P.; Pittet, D.; Auckenthaler, R.; Lew, D. P. et al. Fibronectin, 
fibrinogen and laminin act as mediators of adherence of clinical Staphylococcal 
isolates to foreign material. J. Infect. Dis. 1988, 158, 693-701. 
(39) Vaudaux, P.; Pittet, D.; Haeberli, A.; Huggler, E.; Nydegger, U. E. et al. Host factors 
selectively increase Staphylococcal adherence on inserted catheters: A role for 
fibronectin and fibrinogen/fibrin. J. Infect. Dis. 1989, 160, 865-875. 
(40) Vaudaux, P.; Yasuda, H.; Velazco, M. I.; Huggler, E.; Ratti, I. et al. Role of host and 
bacterial factors in modulating Staphylococcal adhesion to implanted polymer 
surfaces. J. Biomater. Appl. 1990, 5, 134-153. 
(41) Cozens-Roberts, C.; Lauffenburger, D. A.; Quinn, J. A. Receptor-mediated cell 
attachment and detachment kinetics: II. Experimental model studies with the radial-
flow detachment assay. Biophys. J. 1990, 58, 857-872. 
(42) Cozens-Roberts, C.; Lauffenburger, D. A.; Quinn, J. A. Receptor-mediated cell 
attachment and detachment kinetics. I. Probabilistic model and analysis. Biophys. J. 
1990, 58, 841-856. 
(43) Saterbak, A.; Kuo, S. C.; Lauffenburger, D. A. Heterogeneity and probabilistic 
binding contributions to receptor-mediated cell detachment kinetics. Biophys. J. 1993, 
65, 243-252. 
(44) Sauer, K.; Camper, A. K.; Ehrlich, G. D.; Costerton, J. W.; Davies, D. G. 
Pseudomonas aeruginosa displays multiple phenotypes during development as a 
biofilm. J. Bacteriol. 2002, 184, 1140-1154. 
 93
(45) Vadillo-Rodríguez, V.; Logan, B. E. Localized attraction correlates with bacterial 
adhesion to glass and metal oxide substrata. Environ. Sci. Technol. 2006, 40, 2983-
2988. 
 
 
 94
 
 
 
 
 
Chapter 3: 
Morphological analysis of the antimicrobial action of nitric oxide on Gram-negative 
pathogens using atomic force microscopy 
 
3.1  Introduction 
Nitric oxide (NO) is a highly reactive diatomic radical endogenously produced by the 
enzyme-catalyzed oxidation of L-arginine to L-citrulline.  It has been implicated as a 
mediator in multiple physiological processes, ranging from regulatory roles in the 
cardiovascular and nervous system to the inducible host response to infection.1,2  Various 
therapeutic properties attributed to NO, including tumor cytotoxicity,3,4 antimicrobial 
activity, and improved wound healing and tissue integration at implant sites,5  may prove 
beneficial in a number of pharmacological applications.6,7  Due to its reactivity, diverse 
regulatory roles, and short half-life in blood (< 1 sec),8 the ability to target therapeutic NO 
delivery locally is critical.  Nitric oxide donating compounds, such as N-diazeniumdiolates6 
and S-nitrosothiols,9,10 decompose to release NO and hence serve as vehicles for its storage 
and transport.  A number of materials, including nanoparticles,11,12 films and coatings,13,14 
and small molecules,15,16 have employed NO-donor chemistry with varied physicochemical 
and NO-release properties.  
The role of NO in the innate immune response is a conserved feature through a wide 
range of species, from Drosophila to human.17  In mammals, macrophages and other immune 
cells produce NO in response to invading pathogens.18  The antimicrobial properties of NO 
may be elicited by direct modification of biomacromolecules or by formation of reactive 
nitrogen species (RNS) via reaction with oxygen (O2) or superoxide (O2-).19  These RNS may 
render nitrosative stress by the formation of compounds such as dinitrogen trioxide (N2O3) 
and oxidative stress via the formation of peroxynitrite (ONOO-).19-22  The spectrum of 
potential bactericidal mechanisms is thus broad, encompassing DNA damage resulting from 
deamination of deoxyribonucleotides, protein damage via numerous potential reactive sites 
(e.g. heme groups, thiols, amines) that disrupts normal cellular transport and metabolism, and 
membrane damage propagated by radical lipid peroxidation.  The local physiological 
environment plays a key role in determining the metabolic pathways available to NO, and it 
would thus be expected that the bactericidal mechanism(s) of NO produced endogenously in 
phagosomal compartments would differ from NO released extracellularly (e.g., from an 
implanted biomaterial) as a result of differences in local conditions and substrates available 
in the biological milieu.   
In vitro, NO has proven a potent antimicrobial agent effective against a range of 
microorganisms, including both Gram-negative and Gram-positive bacteria.  Gaseous NO 
was found to be toxic against a number of pathogenic species, including C. albicans and 
methacillin-resistant S. aureus.23  N-Diazeniumdiolate-modified NO-releasing surfaces have 
been shown to reduce initial P. aeruginosa adhesion relative to controls,24-26 and kill those 
that do adhere.27  Nitric oxide release from silica nanoparticles has been characterized by 
significant toxicity to bacterial cells with reduced toxicity to L929 mouse fibroblasts.28  
While the bactericidal effects of NO and NO-releasing biomaterials have been demonstrated 
repeatedly, details on the primary targets resulting in bacterial cytotoxicity and the 
corresponding cellular effects of NO on microbial species remain speculative. 
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Morphological analyses of bacteria aid in understanding mechanisms of antibiotic action 
by allowing visualization of changes in the appearance of the microbe undergone subsequent 
to treatment.  While electron microscopy has been employed toward this end for decades,29-31 
atomic force microscopy (AFM) has been used with increasing frequency.32-37  As a surface 
characterization tool, AFM is ideal for morphological studies of surface-adhered bacteria as 
it allows cells to be imaged in situ with high resolution without requiring chemical drying, 
metal coating, or exposure to ultra-high vacuum.  An added benefit of AFM is the flexible 
and adaptable nature of cantilevers as transducers that allow detection of other physical (e.g., 
elasticity) or chemical (e.g., charge distribution) surface parameters simultaneously with the 
acquisition of height information.  Atomic force microscopy has been applied to visualizing 
the antimicrobial action of peptides,32,34,36 chitosan,33 quantum dots,35 and the β-lactam 
antibiotics penicillin and amoxicillin.37   
Herein, we report a morphological analysis of P. aeruginosa and Escherichia coli after 
exposure to NO released from two N-diazeniumdiolate-modified materials: a small molecule 
NO-donor derived from proline (PROLI/NO) and a NO donor-modified xerogel surface 
coating.  The diazeniumdiolate moiety stores two molecules of the antimicrobial agent NO 
on each functionalized amine.  Exposure to proton sources such as buffer and blood catalyzes 
the release of NO.  Using topographical surface mapping and nanometer-scale height 
resolution, changes in bacteria shape and surface roughness were studied as a function of 
exposure time, material, and quantity of NO released. 
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3.2  Experimental 
3.2.1 Materials.  Ethanol and methanol were purchased from Fisher Scientific 
(Pittsburgh, PA).  Argon, NO, nitrogen (N2), and a 25.7 ppm gaseous NO standard in N2 
were purchased from National Welders (Raleigh, NC).  N-(6-aminohexyl) 
aminopropyltrimethoxysilane (AHAP3) was obtained from Gelest (Tullytown, PA).  
Amoxicillin was obtained from Fluka (Buchs, Switzerland).  Isobutyltrimethoxysilane 
(BTMOS), L-proline, sodium methoxide, and dimethylsulfoxide (DMSO) were purchased 
from Sigma-Aldrich (St. Louis, MO).  The amino- and alkoxysilanes were stored over 
desiccant.  The above chemicals were used without further purification.  Distilled water was 
purified with a Millipore Milli-Q UV Gradient A-10 system (Bedford, MA) to a resistivity of 
18.2 MΩ cm. 
3.2.2 Cell culture.  P. aeruginosa (ATCC #19143) and E. coli (ATCC #53323) were 
obtained from American Type Culture Collection (Manassas, VA) and cultured in tryptic soy 
broth (TSB).  Stock cultures were prepared and stored at -80 °C for subsequent experiments. 
A 1-mL aliquot from an overnight culture was inoculated in ~100 mL of TSB and incubated 
at 37 °C for 3-5 h until the culture reached mid-exponential log phase as determined from 
optical density at 600 nm (OD600 = 0.2 ± 0.1), corresponding to ~108 colony forming units 
(cfu) mL-1.  
3.2.3 Synthesis of xerogel films.  Glass slides were coated with a 40% (v:v total silane 
content) AHAP3/BTMOS xerogel film via a 2-step process as described by Marxer et al.13  
Briefly, 120 µl BTMOS was mixed with 60 µl water, 200 µl ethanol, and 10 µl of 0.5 M HCl 
for 1 h.  Then, 80 µl of AHAP3 was added, and the solution was mixed for an additional 
hour.  Glass slides were cut into sections (dim. 13 x 17.5 mm), rinsed with ultrapure water 
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and ethanol, dried under a stream of nitrogen, and cleaned for 30 min in a UV-ozone cleaner 
(BioForce, Ames, IA).  To cast a film, 40 µl of the sol was pipetted onto clean glass slides, 
dried for 30 min at ambient temperature, and cured at 85 °C for 3 d.  Control xerogel films 
were stored in desiccators at 22 °C.   
3.2.4 NO-donor synthesis and characterization.  Xerogels were modified to release NO 
by exposing the films to 5 atm of NO for 72 h as previously described.13  The NO chamber 
was flushed twice with 5 atm Ar to remove atmospheric impurities (e.g., oxygen, water) prior 
to introducing NO gas.  After 3 d, unreacted NO was removed by flushing the vessel with Ar.   
L-proline was converted to PROLI/NO following a procedure previously reported by 
Saavedra et al.16  Briefly, 10 g of L-proline was dissolved in 39 mL of 25% sodium 
methoxide in methanol.  This solution was combined with an additional 20 mL of methanol, 
and exposed to NO gas (5 atm) as described above.  The resulting PROLI/NO formed as a 
white precipitate that was collected via filtration, washed with ether, and vacuum dried.  All 
NO-releasing materials (i.e., PROLI/NO and xerogels) were stored in vials purged with 
nitrogen at -20 °C until use in order to stabilize the NO donor. 
A chemiluminescent nitric oxide analyzer (NOA) (Sievers Model 280, Boulder, CO) was 
used to measure NO release in real time.  A known quantity of the NO-release material was 
placed in a flask containing phosphate buffered saline (PBS, pH = 7.4) positioned in a water 
bath maintained at 37 °C.  The NO generated via diazeniumdiolate decomposition was 
carried into the analyzer via a stream of N2 bubbled into the solution at a flow rate of 80 mL 
min-1.  The detector was calibrated by a 2-point curve using an atmospheric sample passed 
through an NO zero filter and a 25.7 ppm NO standard. 
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3.2.5 Bacterial adhesion to control and NO-releasing xerogels.  Prior to use, the NO-
releasing xerogels were allowed to reach ambient temperature.  Control and NO-releasing 
films were rinsed briefly with ultrapure water and dried under a stream of nitrogen 
immediately prior to bacterial adhesion.  After diluting bacterial suspensions in TSB (1:2 in 
PBS), a 200-µL aliquot of the solution was beaded directly onto the xerogel surface.  
Substrates were covered to reduce evaporation and incubated for either 1 h (in preparation for 
treatment in antibiotic solutions) or 2 h (NO-releasing xerogels) at 37 °C to allow for 
bacterial adhesion. 
3.2.6 Antimicrobial treatment.  For time points exceeding 2 h, NO-releasing xerogels 
with adhered bacteria were placed in vials containing 5 mL of PBS and incubated at 37 °C 
for the remainder of the exposure period.  For treatment with PROLI/NO, the appropriate 
mass was first weighed into chilled, dry vials.  The correct volume of PBS (~5 mL) was 
added to obtain the desired concentration, vortexed briefly, and a control (unmodified) 
xerogel with adhered, untreated bacteria was immediately added to the PROLI/NO solution 
and incubated for 2 h at 37 °C.  Amoxicillin treatment was achieved by preparing a 1 µg mL-
1 solution in PBS from a 9.6 mg mL-1 stock solution in DMSO, into which a control xerogel 
(with adhered bacteria) was placed and incubated for 2 h at 37 °C.  Each xerogel time point 
and antibiotic concentration was replicated for each species studied.  A detailed description 
of the substrate rinsing process is provided below. 
3.2.7 Substrate preparation technique.  A gentle-rinse procedure was developed to ensure 
that adhered cells remained relatively undisturbed for subsequent treatment and/or imaging 
experiments.  A rinse step was accomplished by pipetting a single, 300-µL aliquot of the 
appropriate rinse solution onto the substrate.  Immediately thereafter, the solution was 
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removed with a narrow-tipped pipette in 100-µL increments.  Of note, the pipette was only 
applied to the outer edge of the substrate to remove residual rinse solution so as not to disturb 
the surface to be imaged. 
For both control and NO-releasing xerogels, excess cell suspension in TSB was removed 
from the surface after the adhesion period, followed by five consecutive rinses with PBS to 
remove TSB, non-adhered cells, and trace cellular components.  If adhered cells were 
subsequently treated, the substrate was added to a vial containing the appropriate 
concentration of antimicrobial agent in PBS (PROLI/NO, amoxicillin) for 2 h or PBS (40% 
AHAP3/BTMOS xerogel time points exceeding 2 h) at 37 °C.  The final rinse steps consisted 
of 5 washes with ultrapure water to remove antibiotic and/or salts, after which the substrate 
was dried using capillary action by placing absorbent paper at the edge of the substrate to 
draw excess water off the surface.  A thin layer of water remained, which was allowed to 
evaporate prior to imaging.  It has previously shown that the process of drying bacteria at 
xerogel surfaces does not affect their viability.38 
3.2.8 AFM imaging.  Simultaneous AFM height, amplitude, and phase images were 
obtained in AC mode on the air-dried substrates using an Asylum MFP-3D AFM (Santa 
Barbara, CA).  Olympus AC240TS silicon beam cantilevers (Center Valley, PA) with a 
spring constant of 2 N m-1 and resonant frequency of 70 kHz were used to image bacteria in 
air.  At least three 20 µm2 survey images were obtained at random locations at an interior 
region of each substrate.  Additional images captured control and antibiotic treated cells at 
greater magnifications.  Images were acquired at a resolution of 512 x 512 pixels and scan 
speed of 1 Hz.  Individual root-mean-square (rms) roughness of cell membranes was 
calculated using the MFP-3D software from 500 and 800 nm2 regions of P. aeruginosa and 
 101
E. coli, respectively.  Images used for roughness determination were acquired in the central 
part of a cell and were flattened by one order to reduce contributions from cell curvature at 
the edges of the image.  Membrane roughness values were averaged from at least 3 different 
cells per species, agent, and dose.  Artificial color and light were added to the three-
dimensional reconstructions of height data to aid visualization of image detail. 
 
3.3  Results and Discussion 
3.3.1 Material characterization and experimental design.  Bacterial cells were exposed to 
two NO-releasing materials that differ in their kinetic release profiles.  A representative NO-
release profile and the average integrated dose delivered from a 40% AHAP3/BTMOS 
xerogel film as a function of time are provided in Figure 3.1 and Table 3.1, respectively.  
Nitric oxide is released from these films via a surface flux, increasing rapidly upon exposure 
to aqueous solution and reaching a maximum within half an hour.  Thereafter, the NO release 
gradually reduces to a flux averaging ~50 pmol cm-2 s-1 over 24 h.  Hetrick, et al.27 reported 
that a total dose of NO between 375 and 425 nmol cm-2 delivered from 40 % 
AHAP3/BTMOS xerogels 5 – 7 h after initial bacterial adhesion was sufficient to eradicate 
all adhered P. aeruginosa cells at room temperature.  By contrast, PROLI/NO is a water-
soluble, small molecule diazeniumdiolate NO donor derived from the amino acid proline.  
PROLI/NO releases a bolus of nitric oxide upon breakdown by water.  Due to a short half-
life (t1/2 = 100 s), the majority of stored NO (10.4 ± 2.1 µmol NO mg-1) is released within 300 
s (Table 3.1).  Standard plating experiments indicated a minimum bactericidal concentration 
of 4 and 8 mg mL-1 PROLI/NO after 2 h (MBC120) for E. coli and P. aeruginosa, respectively 
(3-log reduction in cfu).   
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Figure 3.1  Nitric oxide released from a 40% AHAP3/BTMOS xerogel coating in PBS at 37 
°C.
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Table 3.1  Measured NO released from antibacterial materials 
 
 
 
Material NO delivery exposure dose NOb  
xerogel surface flux 2 h 1.32 ± 0.13 (µmol cm-2) 
  4 h 1.93 ± 0.19  
  6 h 2.39 ± 0.23  
  8 h 2.70 ± 0.27  
PROLI/NO bolus 70 s 3.4 ± 1.1 (µmol mg-1) 
  300 sa 8.8 ± 2.0  
 
aThe majority of NO has been released after this time.  The total NO released by 1 mg of 
PROLI/NO is 10.4 ± 2.1 µmol NO. 
bAverage dose of NO reported with standard deviation 
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Nitric oxide release from the materials used in this study was measured in deoxygenated 
PBS per the convention for measuring NO accurately via chemiluminescence.  In contrast, 
the experiments to evaluate the bactericidal effects of these materials were conducted in 
normal PBS (i.e., not deoxygenated), since the bacteria are aerobic.  Nevertheless, control 
experiments indicated that the NO release from AHAP3/BTMOS xerogels in normal PBS 
was indistinguishable from measurements made in deoxygenated PBS over 0 – 24 h, the time 
frame of our experiments (data not shown). 
Due to the nature of diazeniumdiolate decomposition to NO (at physiological pH and 
temperature), bacterial adhesion to NO-releasing xerogel films occurs concurrently with 
exposure of the bacteria to a local NO flux.  Although slower compared to control xerogels, 
the surface coverage of P. aeruginosa to NO-releasing 40% AHAP3/BTMOS xerogels have 
been shown to reach a steady state at 60 min under static conditions.27  For these 
experiments, NO-releasing surfaces were exposed to cell suspensions for 2 h, followed by 
removal of loose cells and preparation of substrates for imaging (for 2 h time points) or 
transfer of the substrates to PBS (for extended time points).   To apply a similar approach for 
treatment with antibiotic solutions (i.e., PROLI/NO and amoxicillin), bacteria were allowed 
to adhere to control xerogel substrates for an hour prior to transfer of the cell-covered 
substrate to a vial of antibiotic solution.  Treating surface-adhered cells with antibacterial 
agents provided the added benefits of capturing cell damage and debris locally on the surface 
at the time of treatment while more nearly approximating an infection-causing scenario.   
3.3.2 Morphologies of P. aeruginosa and E. coli adhered to control xerogels.  Control 
40% AHAP3/BTMOS xerogels have been reported to be non-toxic to bacteria adhered at 
exposure periods > 24 h.38  Thus, they represent a suitable substrate for the study of normal 
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morphologies, while providing a consistent sub-stratum for comparison of healthy and 
antibiotic-treated (solution) cells to those treated via a surface flux of NO.  Representative 
images of untreated P. aeruginosa and E. coli cells adhered to control xerogels are illustrated 
in Figure 3.2.  P. aeruginosa cells are rod-shaped and exhibit regular dimensions (~ 1 x 3 
µm) with an inflated appearance and smooth cell exterior.  Also rod-shaped, E. coli are 
somewhat larger and more variable in length.  On control surfaces, P. aeruginosa adhered in 
well organized patterns that maximized contact along the long axis of the cells while 
maintaining apparent structural integrity.  By comparison, E. coli cells tended to maintain 
some physical separation (i.e., adhering individually or in small groups of 2 to 3 cells).  
While P. aeruginosa are motile via flagella, E. coli have a characteristic crown of fimbriae.  
Healthy cells of both species appeared intact with no visible pores, holes, grooves, or 
breakages in the cell envelope.  To negate any possible effect derived from the presence of 
proline, E. coli and P. aeruginosa preadsorbed on control xerogels were incubated for 2 h 
with 2 and 4 mg mL-1 proline, respectively.  Physically, the proline exposed cells were 
indistinguishable from untreated cells.  Equivalent cell viability was verified by growing 
colonies on nutrient agar. 
3.3.3 Morphologies of NO-treated P. aeruginosa and E. coli.  Sub-bactericidal 
concentrations such as those used in this study have historically been applied to study 
antimicrobial effects as they provide ‘snapshots’ of the organism’s morphology between 
healthy and dead states.31,34,39  Figure 3.3 illustrates examples of P. aeruginosa and E. coli 
bacteria after exposure to NO.  A representative collection of images was chosen to 
demonstrate the full spectrum of related morphologies resulting from NO treatment.  Many 
of the effects of NO exposure (e.g., membrane degradation) were exhibited at multiple doses.   
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Figure 3.2  Deflection images depict the morphology of healthy (A) P. aeruginosa; and (B) 
E. coli bacteria. 
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Figure 3.3  Three-dimensional reconstructions of height images illustrate P. aeruginosa and 
E. coli morphologies, shown in the left and right columns, respectively.  Parts (A-E) depict 
cells treated by NO flux from 40% AHAP3/BTMOS xerogels for (A, C) 4 h; (B) 6 h; (D, E) 
8 h.  Parts (F-J) show examples of bacteria treated with sub-bactericidal concentrations of 
PROLI/NO for 2 h at (F-H) 1 mg mL-1; (I) 4 mg mL-1; and (J) 2 mg mL-1.   
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A comprehensive list of the morphologies observed after treatment with NO is included in 
Table 3.2.  Many bullets are identical or similar for each species indicating related 
mechanisms of action against both Gram-negative bacteria.  Such features include mild to 
extensive membrane degradation, debris present on the surface in the vicinity of cells, 
blebbing or cellular parts abnormally attached to cells, cellular collapse, and lysis.  
Spheroplast formation and increasingly short cellular length were more infrequent 
morphologies common to both species, generally observed on xerogels after longer 
exposures to surfaces fluxes of NO (6 – 8 h, Fig. 3.3D-E).  Neither species exhibited 
population arrangements on NO-releasing xerogels similar to those observed on controls.  P. 
aeruginosa adhered in a disorganized array, while E. coli cells abandoned their active 
tendency to maintain spatial separation on a surface.  Cells were occasionally observed to 
adhere across a previously adhered cell, despite a low overall surface coverage. 
The collection of morphologies observed indicates cell envelope damage as a visible and 
significant contributing mechanism to the cytotoxic effect of NO against P. aeruginosa and 
E. coli.  The morphologies observed in this AFM study closely resemble those reported by 
Li, et al.34 who concluded that their antibacterial peptides disrupted, permeabilized, and 
eventually destroyed the stability of the outer and inner lipid membranes of P. aeruginosa 
and E. coli.  The single morphology that points strictly to protein damage in this study, the 
broken fimbriae frequently observed for E. coli, also occurred at the cell membrane.  Nitric 
oxide-mediated membrane damage has recently been reported by Hetrick, et al.28 using 
confocal fluorescence microscopy.  In that study, P. aeruginosa membranes became 
permeable to propidium iodide, a fluorescent dye that may only enter bacterial cells with  
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Table 3.2  Morphologies exhibited by Gram-negative bacteria after NO treatment 
 
 
 
P. aeruginosa            E. coli 
 
 Cellular debris  Cellular debris 
• Granule-like particles near cell • Most often concentrated on surface in 
vicinity of cell • Occasionally cell-associated 
 Membrane degradation • Occasionally cell-associated 
 Membrane degradation • Large increases in surface roughness 
• Increased surface roughness • Bumps and crevices in cell surface 
 Cell collapse • Layered appearance 
 Cell lysis • Pores and crevices easily visualized 
 Decreased height and length  Cell collapse 
 Spheroplast formation • Lower height (< ~30 nm) 
 Damage at apical ends and along sides of 
cell 
• Flatter appearance 
• Some internal structures visible • Frequent collapse of apical ends  Cell lysis • Collapse of specific regions of the cell  Decreased cell length 
° Usually along edge of cell   Spheroplast formation  
° Occasionally in cell interior  Breakage 
 Blebbing  Broken fimbriae  
 110
compromised membranes, after exposure to NO-releasing silica nanoparticles (maximum NO 
flux ≈ 21,700 ppb mg-1). 
Both delivery routes used in this study released NO exterior to, but in the vicinity of, 
surface-adhered bacteria.  As a broad-spectrum antibiotic, NO exerts both oxidative and 
nitrosative stress on biomolecules at cell surfaces.  Physically, NO and O2 are lipophilic and 
membrane permeable leading to the concentration and sequestering of these molecules and 
their reactive metabolites (e.g., N2O3) near lipid bilayers,21 where membrane-bound and other 
local proteins become targets of nitrosative stress.  The formation of peroxynitrite from the 
reaction of NO with intracellular O2- initiates the radical peroxidation of lipid membranes 
(oxidative stress), potentially the cause of the observed degradation of these structural 
components.   
3.3.4 Analysis of membrane roughness after NO treatment.  To further characterize the 
effect of NO on the Gram-negative cell, AFM images were obtained of the bacterial 
membrane.  The cell membrane damage by NO was readily observed in representative three-
dimensional reconstructions from height images after 2, 4, 6, and 8 h exposures to NO flux 
from xerogels (Fig. 3.4). The vertical scale is consistent across images (15 nm) to allow 
comparison between AFM images.  Gram-negative cell envelopes are composed of an outer 
and inner lipid membrane, each about 10 nm thick, separated by a thin, cross-linked 
peptidoglycan layer.  Holes in the outer lipid membrane began forming as early as 2 h (Fig. 
3.4B) after exposure to NO surface fluxes.  Over time, the degree of membrane degradation 
continued to increase, with large holes and crevices penetrating into the inner membrane (Fig 
3.4C-E).  In fact, at exposure times exceeding 4 h the roughness of the membrane exceeded 
the height scale.  The image analysis software was then used to apply light/shadow at  
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Figure 3.4  P. aeruginosa membranes on a control surface (A), and after exposure to NO 
surface flux for (B) 2 h, (C) 4 h, (D) 6 h, and (E) 8 h from a 40% AHAP3/BTMOS xerogel, 
and (F) after exposure to 0.07 µM NO in solution (bolus delivery). 
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 identical angles and pitch to add a sense of depth.  By comparison, Figure 3.4A depicts the 
membrane of a healthy P. aeruginosa cell adhered to a control xerogel for 24 h.  Its 
morphological analysis confirms that changes in membrane roughness are a function of NO-
exposure and not surface residence time. 
The quantitative rms roughness of cell membranes as a function of bacteria species and 
NO exposure time/concentration is given in Table 3.3.  As expected, longer exposure to a NO 
surface flux (40% AHAP3/BTMOS xerogels) correlates with rougher cell membranes 
ranging from ~1.6 nm for controls to nearly 4 and 12 nm after 8 h NO release for P. 
aeruginosa and E. coli, respectively.  Similarly, membrane roughness was greater for E. coli 
for cells treated with greater concentrations of PROLI/NO (15.2 ± 4.6 and 28.9 ± 7.9 nm for 
1 and 2 mg mL-1, respectively) (Fig. 3.5). Of note, the measured roughness for P. aeruginosa 
was the same at both sub-bactericidal (MBC120 of PROLI/NO for P. aeruginosa is 8 mg mL-
1) concentrations of PROLI/NO (2 and 4 mg mL-1), and approximately double that measured 
for the longest exposure to NO-releasing xerogels. If the deterioration of the lipid bilayer 
leads to increased surface roughness, this may be indirect evidence that protein and/or DNA 
damage contributes significantly to the cytotoxic effect of PROLI/NO against this species. 
3.3.5 Comparison of morphologies resulting from NO and amoxicillin treatment.  
Amoxicillin, a β-lactam antibiotic, functions by inhibiting enzymes that cross-link chains in 
the peptidoglycan layer.  Treatment of E. coli with a sub-bactericidal concentration of 
amoxicillin was therefore expected to generate morphologies typical of cell wall degradation.  
(P. aeruginosa was not treated with amoxicillin as it has demonstrated resistance to the 
effects of this β-lactam.)  The most common morphologies observed by imaging amoxicillin- 
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Table 3.3  Root-mean-square (rms) roughness of cell membranes 
 
species material exposure average (nm)a
P. aeruginosa xerogel control 1.61 ± 0.27 
  2 h 2.13 ± 0.09 
  4 h 2.25 ± 0.30 
  6 h 3.20 ± 0.31 
  8 h 3.84 ± 0.76 
 PROLI/NO 2 mg mL-1 7.15 ± 1.52 
  4 mg mL-1 7.10 ± 0.86 
 NO solution 0.07 µM 3.16 ± 0.61 
E. coli xerogel control 1.55 ± 0.21 
  2 h 2.66 ± 0.66 
  4 h 3.24 ± 0.45 
  6 h 4.33 ± 0.55 
  8 h 11.7 ± 1.9 
 PROLI/NO 1 mg mL-1 15.2 ± 4.6 
  2 mg mL-1 28.9 ± 7.9 
 
aAverage rms roughness reported with standard deviation  
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Figure 3.5  Three-dimensional reconstructions of E. coli membranes compare (A) untreated 
relative to (B) the degradation sustained after 6 h NO-release from a xerogel surface.  
Treatment with sub-bactericidal PROLI/NO concentrations of (C) 1 mg mL-1 and (D) 2 mg 
mL-1 show more extensive damage only 2 h after exposure.  Note the difference in scale 
range. 
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treated E. coli were perforations in the cell surface (pore formation) and regions of collapsed 
cell wall, both concentrated (but not restricted to) the apical ends of the cells (Fig. 3.6C, D).  
These observations are in agreement with a study that used AFM to compare the 
morphological changes sustained by E. coli after treatment with amoxicillin and its parent 
molecule, the natural product penicillin.37  Both E. coli (Fig. 3.6A) and P. aeruginosa (Fig. 
3.6B) exhibited analogous morphologies to the amoxicillin-treated cells when treated with 
low levels of NO.  In fact, these morphologies were only visualized on NO-releasing 
xerogels at 2 h time points, and thus at the lowest concentrations of NO treatment used in this 
study.  At greater NO doses, these morphologies were obscured as the extent of membrane 
damage increased and the incidence of localized effects decreased.  Interestingly, the 
morphologies observed for treatment of E. coli with penicillin, described by Yang, et al.37 as 
randomly distributed grooves and holes, strongly resemble the morphological changes 
sustained by both E. coli and P. aeruginosa at greater NO doses.  The similarity of 
morphologies observed after treatment with amoxicillin, which functions by a known 
mechanism of action, to those after exposure to NO offers additional support to the 
conclusion that exposure to NO results in the deterioration of the cell envelope of Gram-
negative bacteria. 
3.3.6 Comparison of NO delivery methods.  Comparing NO-delivery methods proved less 
straightforward than varying exposure time or concentration for a single delivery method.  
Both the NO-release kinetics (slow versus fast) and manner of delivery (surface flux versus 
burst of NO release) differ for 40% AHAP3/BTMOS xerogels and PROLI/NO.  While 
treatment with PROLI/NO resulted in rougher, more highly deteriorated cells than exposure 
to a sustained surface flux as visualized qualitatively (Fig. 3.3) and measured quantitatively  
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Figure 3.6  Comparison of the morphological effects caused by treatment with NO on (A) E. 
coli and (B) P. aeruginosa strongly resemble the morphologies demonstrated by E. coli after 
treatment with (C) amoxicillin, a β-lactam that inhibits cell wall synthesis.  Furthermore, the 
three-dimensional rendering of (D) the compromised cell wall after treatment with 
amoxicillin resembles the holes and crevices exhibited by P. aeruginosa and E. coli after NO 
treatment, which is indicative of membrane damage. 
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(Table 3.3), the total amount of NO released as a bolus from sub-bactericidal concentrations 
of PROLI/NO exceeded that delivered by sub-bactericidal fluxes of NO from 
40%AHAP3/BTMOS.  As the molecules of NO released from PROLI/NO were dispersed 
throughout the solution rather than being concentrated at the location of bacterial adhesion 
(i.e., at the surface), this may explain the significantly greater quantities of NO necessary 
induce a bactericidal effect.   
To deconvolute the efficacy of the delivery routes, P. aeruginosa cells were treated with 
a bolus of NO slightly less than that delivered by a 40% AHAP3/BTMOS xerogel over 2 h.  
Xerogel-adhered P. aeruginosa cells were immediately added to a 0.07 µM solution of NO in 
5 mL of PBS (prepared from a saturated NO solution) and incubated for 2 h under conditions 
identical to the PROLI/NO experiments.  The membrane roughness remained greater when 
cells were treated by a bolus compared to surface flux from an NO-releasing 40% 
AHAP3/BTMOS xerogel (3.2 ± 0.6 nm vs. 2.1 ± 0.1 nm, respectively) (Table 3.3), and a 
comparison of the P. aeruginosa membrane after treatment with an NO solution (Fig. 3.4F) 
to that after 2 h exposure to surface flux (Fig. 3.4B) clearly demonstrates larger pores and 
crevices in the former. 
Bacterial species have evolved strategies to protect against the harmful effects of NO.40  
For example, specific transcription factors (e.g., SoxR, OxyR) identified in E. coli are 
capable of sensing NO released from macrophages and respond by up-regulating gene 
expression to combat toxic effects.41,42  Once detected in vivo,  these proteins convert NO to 
less toxic by-products such as nitrate.43  Although the molecules of NO released from 
PROLI/NO are dispersed throughout the medium, the total concentrations of NO and RNS 
available to react with the adhered cells are greater during the initial period of incubation 
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when they are released via a bolus.  Delivered in a highly concentrated burst, NO may 
devastate bacterial cells before they are capable of mounting a defense.  As an extension of 
this hypothesis, future studies should investigate the behaviour of bacteria selected after 
exposure to increasing concentrations of NO in an attempt to foster tolerance and probe the 
upper limit of resistance to NO. 
 
3.4 Conclusions  
The morphologies of two Gram-negative species of bacteria were observed using AFM 
after treatment with the antimicrobial agent NO.  Quantitative measurements of surface 
roughness and qualitative observation of increased surface debris and changes in cell shape 
(e.g., blebbing) and adhesion patterns indicate that membrane degradation is a significant 
contributing factor to NO’s bacterial cytotoxicity.  Comparison of morphological effects 
perpetrated via a single, known mechanism (i.e., inhibition of cell wall synthesis by 
amoxicillin) to those observed from treatment of NO aids in confirming the antimicrobial 
mechanism of the latter.  By evaluating NO sources with different NO-release kinetics, we 
conclude that greater levels of NO released over short durations are more damaging to Gram-
negative bacteria than sustained, lower-level surface fluxes.  The double lipid bilayer of 
Gram-negative bateria typically acts as a permeability barrier to antibiotics that function 
within the cell.  Ironically, it is this same structural characteristic that renders these cells 
particularly susceptible to NO-induced membrane damage.  As degradation of the cell 
envelope leads to an increase in permeability, treatment with NO may elicit synergistic 
effects when used in concert with antibiotics. 
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Chapter 4: 
Synergy of nitric oxide and silver sulfadiazine against Gram-negative, -positive, and 
antibiotic-resistant bacteria 
 
4.1 Introduction 
The antimicrobial properties of silver or more specifically ionic silver (Ag+) have been 
recognized and utilized for millennia.  Nano- to micromolar concentrations of Ag+ exhibit 
broad-spectrum bactericidal (including Gram-negative and Gram-positive species), 
fungicidal, viricidal, and protozoicidal activity,1 bonding covalently to electron-donating 
groups (e.g., the sulfhydryl of cysteine) or electrostatically to negatively charged molecules 
(e.g., DNA).  Most bacterial sites targeted by Ag+ are proteinaceous, where alterations in 
amino acid residues lead to structural damage and disruption of replicative and metabolic 
processes resulting in cell death.1-6  Evidence suggests that interactions with DNA also play 
an important role in the antimicrobial efficacy of Ag+.4,5  In wound treatment, Ag+ is 
generally delivered via silver compounds such as silver (I) sulfadiazine (AgSD).7  Most 
causative pathogens related to burns and chronic wound infections are susceptible to the 
levels of AgSD attainable topically.8,9  Fortunately, exposure to clinical levels of Ag+ 
generally does not pose a threat to human health, despite the broad range of reactivity.1,7 
The endogenous expression of nitric oxide (NO) has been conserved throughout higher 
organisms as the immune system’s first-line defense against infection.10-13  Like Ag+, NO is a 
broad-spectrum antimicrobial agent that targets a number of reactive sites.  Although NO can 
modify proteins and other biological macromolecules directly,14 it is a highly reactive radical 
and frequently combines with locally abundant small molecules such as oxygen (O2) and 
superoxide (O2-) creating an arsenal of reactive byproducts that include dinitrogen trioxide 
(N2O3) and peroxynitrite (ONOO-).11,15  Collectively these reactive species evoke potent 
antibacterial effects by rendering nitrosative and oxidative stresses to bacteria.11,15-19  In vitro, 
NO administered from both a gas cylinder and via soluble, small-molecule diazeniumdiolate 
NO donors has been shown to kill a range of pathogens.20-22  Furthermore, our group has 
demonstrated the bactericidal activity of NO-releasing xerogel coatings that simultaneously 
reduce the incidence of bacterial adhesion.23-25  These studies suggest that site-directed NO 
delivery is a promising strategy for treatment of infection.   
Although the appropriate use of antimicrobials to treat infection is a beneficial practice, 
artificial pressures resulting from over use, patient non-compliance, and widespread 
application have promoted the unnatural selection of inherently resistant microbes.26  Even 
resistance to broad-spectrum agents has been observed.7,27  To complicate matters, methods 
of gene sharing employed by bacteria promote the localized collection of resistance 
determinants, often on transferable plasmids, leading to the emergence of multi-drug resistant 
(MDR) and extensively drug resistant (XDR) species.28,29  In recent years, a dramatic rise in 
the incidence of ‘super bugs,’ or bacteria that are resistant to those antibiotics generally 
reserved as a last resort treatment option, has become prevalent.30,31  Unfortunately, the 
discovery of new antimicrobials progresses slowly while resistance to all clinically employed 
antimicrobial agents rapidly continues to emerge,26 highlighting the critical need for 
alternative approaches to treating infection. 
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Combination therapy is one strategy for stemming the emergence of resistant species.32-34  
The concerted use of two or more biocides with different mechanisms of action decreases the 
likelihood that an organism will possess all the traits necessary to ensure its selection and 
survival.  Agents possessing a broad spectrum of antimicrobial action may both lower the 
probability of developing resistance and manage the polymicrobial burden typically found in 
topical infections.33,34  As smaller quantities of each drug are generally required in the 
application of combination therapy, dose-related toxicity experienced to a particular biocide 
may also be reduced.33,34  Finally, the combination of certain antimicrobials may result in 
synergistic effects.33,34  Synergistic combinations are more potent than equivalent doses 
administered individually, further reducing potential toxicity to the patient and cost of 
treatment.  Herein, NO generated from diazeniumdiolate-modified proline (PROLI/NO) and 
AgSD were evaluated alone and in combination using acute (2 h) viability assays to 
determine in vitro efficacy against two Gram-negative and four Gram-positive pathogenic 
strains of bacteria, including two antibiotic-resistant ‘super bugs’.  
 
4.2 Experimental 
4.2.1 Materials.  L-proline, sulfadiazine (SD), and AgSD were obtained from Sigma-
Aldrich (St. Louis, MO).  Tryptic soy broth (TSB) and tryptic soy agar (TSA) were 
manufactured by BD (Franklin Lakes, NJ) and purchased from Fisher Scientific (Pittsburgh, 
PA).  Sodium chloride, potassium chloride, and sodium phosphate monobasic obtained from 
Fisher and sodium phosphate dibasic obtained from Sigma-Aldrich were used to prepare 
phosphate buffered saline (PBS, Ic = 0.16 M, pH = 7.4).  Distilled water was purified using 
the Millipore Milli-Q UV Gradient A-10 system (Bedford, MA) to a resistivity of 18.2 MΩ 
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cm and used to prepare the reagents for bactericidal assays.  Materials used for growing 
bacteria and/or evaluating bactericidal activity were exposed to UV radiation or sanitized in 
an autoclave prior to use, unless purchased sterile.   Argon, NO, nitrogen (N2), and a NO 
standard (25.7 ppm in N2) were purchased from National Welders (Raleigh, NC). 
4.2.2 Cell culture.  The strains of bacteria used in this study were obtained from 
American Type Culture Collection (ATCC, Manassas, VA).  The ATCC identification 
number for each strain was as follows: E. coli (53323), vancomycin-susceptible E. faecalis 
(VSEF) (29212), vancomycin-resistant E. faecalis (VREF) (51299), P. aeruginosa (19143), 
methacillin-susceptible S. aureus (MSSA) (29213), methacillin-resistant S. aureus (MRSA) 
(33591). Experiments requiring transfer of biohazardous materials were conducted in a 
dedicated laminar flow hood equipped with UV lamp.  Lyophilized bacteria were 
reconstituted in TSB and cultured overnight at 37 °C.  A 1-mL aliquot of culture was grown 
in 100 mL of TSB for 2-4 h until reaching an optical density at 600 nm (OD600) ~ 0.15-0.3.  
The resulting culture was stored at -80 °C in 1-mL aliquots.  For daily experiments, 1 mL of 
bacteria culture was grown in 100 mL of TSB overnight at 37 °C.  Re-cultured in fresh TSB 
the next day, the bacteria were then grown to mid-exponential phase, as determined by OD600 
measurements.  The relationship between the OD600 and the concentration of bacteria in the 
culture suspension was calibrated for each strain using a Spectronic 301 spectrophotometer 
(Milton Roy, Ivyland, PA) and enumeration of cfu from culture dilutions grown on TSA 
plates.   
4.2.3 Synthesis and characterization of PROLI/NO.  The synthesis protocol reported by 
Saavedra, et al. was used in the preparation of PROLI/NO.35  Briefly, 10 g of L-proline was 
dissolved in 39 mL of 25% sodium methoxide in methanol.  An additional 20 mL of 
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methanol was added, and the solution was placed into a custom NO reaction bomb, which 
was then purged with Ar.  The proline solution was then exposed to 5 atm of NO for 3 d to 
form PROLI/NO as a white precipitate in the methanol.  After purging the bomb with Ar, the 
precipitate was isolated by vacuum filtration, washed with ether, and dried under vacuum.  
The white solid (PROLI/NO) was divided into small aliquots (< 1 g) and stored over 
dessicant at -20 °C.   
Nitric oxide release from PROLI/NO was characterized using a chemiluminescent NO 
analyzer (Sievers Model 280, Boulder, CO).  Briefly, a known quantity of PROLI/NO was 
inserted into a glass flask containing PBS at 37 °C.  Nitric oxide generated into solution via 
diazeniumdiolate NO donor decomposition was carried to the analyzer by N2 bubbling 
through the solution at a flow rate of 80 mL min-1.  The NO analyzer was calibrated using an 
atmospheric sample passed through an NO zero filter and a 25.7 ppm NO standard.  The NO 
release from PROLI/NO was measured periodically to ensure no significant decomposition 
of the NO donor over the duration of the study. 
4.2.4 Single-agent bactericidal assays.  The bactericidal efficacy of single agents (e.g., 
AgSD, PROLI/NO) was evaluated against each pathogenic strain of bacteria using a 
technique adapted from the standard microdilution broth procedure as described below.36  
The minimum bactericidal concentration at 120 min (MBC120) was defined as the 
concentration of AgSD or PROLI/NO that resulted in a 3-log reduction in viability for a 
particular bacteria species over 120 min.  Each strain of bacteria was tested against 5 
concentrations each of AgSD and PROLI/NO.  The antimicrobial concentrations tested were 
adjusted such that at least one concentration bracketed the MBC120 at low and high levels, 
and the results were verified in independent replicates (n = 3).  To prevent thermal 
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decomposition of the NO donor moiety, PROLI/NO was pre-weighed into chilled vials, and 
the appropriate volume of cell suspensions was added to obtain the target PROLI/NO 
concentration.  The bactericidal assays were conducted at 37 °C with shaking, and cell 
viability was assessed at 0, 60, and 120 min by plating aliquots of the treated bacteria diluted 
in PBS on TSA plates.  The toxicity of SD and proline were evaluated at the concentrations 
equivalent to and via the protocols used for determining the MBC120 of AgSD and 
PROLI/NO, respectively. 
4.2.5 AFM imaging.  Atomic force microscopy was employed to visualize the 
membrane degradation rendered to E. coli by treatment with sub-bactericidal concentrations 
of PROLI/NO.  Bacteria were adhered to a non-toxic substrate as described previously37 and 
treated with sub-bactericidal concentrations of PROLI/NO (1 and 2 mg mL-1) for 2 h.  
Control (untreated) and NO-treated cells were imaged in air using AC mode with Olympus 
AC240TS silicon beam cantilevers (Center Valley, PA) possessing a spring constant of 2 N 
m-1 and resonant frequency of 70 kHz.  Simultaneous height, amplitude, and phase images 
were acquired at a resolution of 512 x 512 pixels and a scan speed of 1 Hz. 
4.2.6 Checkerboard assay.  The checkerboard method33 was employed to determine the 
efficacy of AgSD and PROLI/NO in combination.  Modifications analogous to those used in 
the single-agent bactericidal assays were adopted as described below.  Briefly, bacteria were 
incubated with an array of antimicrobial combinations of AgSD and PROLI/NO for 2 h at 37 
°C.  The highest concentration for each antimicrobial (arbitrarily termed agent A and B) 
initially tested was chosen at half its MBC120, as determined in the single-agent assay.  Three 
additional dosages at stepwise, two-fold reductions in concentration were evaluated, resulting 
in 16 total combinations of AgSD and PROLI/NO tested against each strain of bacteria.  For 
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strains that were particularly susceptible to the combination (i.e., MSSA, VSEF, VREF), 
lower concentrations of each agent were selected to probe the synergistic limit.  Again, viable 
cells were enumerated at 0, 60, and 120 min.  The fractional bactericidal concentration index 
at 120 min (FBC120) was calculated using Equation 4.1: 
 
120 120
120
120 120
AB BA
A B
MBC MBCFBC
MBC MBC
= +        Eq. (4.1) 
 
adapted from the fractional inhibitory concentration index (FIC) reported by Elion et al.,38 
where MBC120A and MBC120B are the values determined for agent A and B, respectively, in 
the single-agent assay; and, MBC120AB and MBC120BA are the concentrations of agent A and 
B that constituted the most effective bactericidal combination as determined by a 3-log 
reduction of viability.  Synergy assays were conducted in three independent experiments for 
each strain of bacteria.  A FBC120 < 0.5 was defined as synergistic, while a FBC120 < 0.25 
was considered highly synergistic. 
 
4.3 Results 
4.3.1 Bactericidal activity of AgSD and PROLI/NO independently.  The MBC120 values 
for AgSD and PROLI/NO were evaluated against two Gram-negative (P. aeruginosa and E. 
coli) and four Gram-positive (VSEF, VREF, MSSA, and MRSA) pathogenic species of 
bacteria, including two antibiotic-resistant ‘super bugs’.  The MBC120 was assigned as the 
integer concentration that was repeatedly identified as producing a 3-log reduction in 
viability.  Broth microdilution experiments indicated an extensive bactericidal range for 
AgSD spanning 3 orders of magnitude (Table 4.1).  P. aeruginosa exhibited levels of  
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Table 4.1 Bactericidal activity of AgSD and PROLI/NO independently and in combination. 
 
 
 
 
Species Gram class 
MBC120 
AgSD 
(mg L-1) 
MBC120 
AgSD 
(mmol L-1) 
MBC120 
PROLI/NO 
(g L-1) 
MBC120
total NO 
(mmol L-1) 
FBC120
P. aeruginosa - 5 0.014 8 83 0.58 ± 0.04 
E. coli - 50 0.14 4 42 0.34 ± 0.04 
S. aureus + 50 0.14 12 130 0.23 ± 0.07 
E. faecalis + 2000 5.60 18 190 0.07 ± 0.01 
MRSA + 200 0.56 18 190 0.52 ± 0.08 
VREF + 2000 5.60 30 310 0.15 ± 0.03 
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susceptibility in the low micromolar range (14 µM, 5 mg L-1) comparable to previous 
reports.4,39  The bactericidal concentrations for E. coli and MSSA were a full order of 
magnitude greater (140 µM, 50 mg L-1) than P. aeruginosa, while MRSA required a four-
fold greater dose (560 µM , 200 mg L-1) than the MSSA strain.  Both Enterococcus strains 
required a ten-fold greater dose to achieve a 3-log reduction in viability (5600 µM, 2000 mg 
L-1) compared to MRSA.   
Bactericidal concentrations of PROLI/NO also varied significantly between pathogens.  
The Gram-negative species E. coli and P. aeruginosa required the lowest PROLI/NO doses 
at 4 g L-1 (42 mmol L-1 NO) and 8 g L-1 (83 mmol L-1 NO), respectively.  The most 
susceptible Gram-positive strain was MSSA, with an MBC120 of 12 g L-1 (130 mmol L-1 
NO), followed by VSEF and MRSA, both requiring 18 g L-1 (190 mmol L-1 NO).  VREF 
exhibited the greatest resistance to NO, tolerating concentrations of PROLI/NO up to 30 g L-
1 (310 mmol L-1 NO).   
To verify that dissociated SD or regenerated proline did not contribute to observed 
cytotoxicity, we examined the bactericidal activity of these compounds with similar testing 
protocols.  Molar concentrations of SD equaling the MBC120 for AgSD against each of the 6 
pathogens studied proved overwhelmingly non-toxic to the bacteria, having neither a 
bacteriostatic nor bactericidal effect.  In all cases the bacteria continued to multiply during 
treatment, such that populations increased between 2- to 10-fold over 2 h.  Proline exhibited 
a similar non-toxic effect at concentrations equaling the MBC120 of PROLI/NO for each 
species.  Thus, the bactericidal activity of AgSD and PROLI/NO as single agents can be 
ascribed to Ag+ and NO, respectively, under the experimental protocol adopted against these 
pathogens in this study. 
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The Gram-positive species studied generally exhibited superior tolerance to the single 
agents, Ag+ and NO, than the Gram-negative species.  Indeed, the two strains of E. faecalis 
indicated the greatest tolerance to both PROLI/NO and AgSD.  The resilience of these strains 
mirrors a report on the efficacy of dilute honey, another broad-spectrum antimicrobial, 
against a variety of bacterial species, where E. faecalis again displayed exceptional 
fortitude.40  Among the Gram-positive species examined in our study, the antibiotic-resistant 
strains tended to demonstrate greater tolerance to each biocide than their antibiotic-
susceptible congeners.  We observed that MRSA exhibited significantly greater tolerance to 
both Ag+ and NO than its methicillin-susceptible counterpart.  Similarly, VREF required 
nearly twice the dose of PROLI/NO than the vancomycin-susceptible strain.  The 
phenomenon that resistant bacteria selected by exposure to one antimicrobial frequently 
demonstrate resistance to other agents has been documented repeatedly.41-43   
By determining cell viability at one or more intermediate time points, the dose-response 
of bacteria to a drug may be monitored over time, circumventing the all-or-none result 
typically obtained from inhibition or endpoint-only bactericidal assays.   Figure 4.1 depicts 
cell viability for each species treated with MBC120 concentrations of AgSD and PROLI/NO at 
0, 1, and 2 h.  Most bacteria have already undergone a full log reduction in viability by the 
first 60 min, indicating swift bactericidal action.  The Gram negative strains suffered a less 
drastic decrease in viability in the first hour after treatment with AgSD than Gram-positive 
bacteria. 
4.3.2 Synergistic activity of AgSD and PROLI/NO in combination. Using the 
checkerboard technique and Eq. 4.1, FBC120 values were determined to evaluate the 
combined efficacy of AgSD and PROLI/NO against P. aeruginosa, E. coli, VSEF, VREF, 
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Figure 4.1  Bacteria viability over 120 min obtained using assays to evaluate the efficacy of 
PROLI/NO and AgSD independently and in combination.  Curves indicate representative 
data obtained at MBC120 and FBC120 levels for (A) E. coli, (B) P. aeruginosa, (C) VSEF, (D) 
VREF, (E) MSSA, and (F) MRSA.  Each inset lists the concentration of PROLI/NO (CP) and 
the concentration of AgSD (CA) used to obtain the FBC120 curve. 
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MSSA, and MRSA.  The FBC120 values provided in Table 4.1 were averaged from 3 
independent checkerboard arrays.  Bactericidal synergism (FBC120 < 0.5) was evident for 4 
out of 6 species tested, including VREF.  Two species (P. aeruginosa and MRSA) exhibited 
FBC120 values near 0.5 and, under the acute treatment duration, may have experienced a 
borderline synergistic effect. Two species (P. aeruginosa and MRSA) exhibited FBC120 
values near 0.5 and, considering the acute treatment duration, may have experienced a 
borderline synergistic effect.  While Gram-positive bacteria were least susceptible to both 
AgSD and PROLI/NO as individual antimicrobial agents, the combination of AgSD and 
PROLI/NO was most synergistic against these same species. A highly synergistic effect 
(FBC120 < 0.25) was observed for half of the strains tested, all of which were Gram-positive 
species. Both E. faecalis strains demonstrated the greatest tolerance to each agent 
individually, but suffered the highest degree of susceptibility to the combination of AgSD 
and PROLI/NO, with FBC120 values of 0.15 and 0.07, respectively.  The MSSA strain also 
exhibited a high degree of susceptibility to this combination (FBC120 = 0.23), although 
MRSA was affected to a lesser degree (FBC120 = 0.52).  The lowest degree of cooperativity 
was observed for P. aeruginosa (FBC120 = 0.58). Notably, this species was the most 
susceptible, by an order of magnitude, to AgSD alone.  E. coli, the other Gram-negative 
species studied, exhibited an FBC120 of 0.34.  Representative cell viability data for all species 
at synergistic levels of AgSD and PROLI/NO are shown in Figure 4.1.  The synergistic 
combinations, like the bactericidal concentrations for single agents, also show a high efficacy 
in the first hour, as cell viability was again reduced by a full log in all cases except the 
antibiotic resistant strains. 
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4.4 Discussion 
4.4.1 Bactericidal efficacy of PROLI/NO and AgSD.  To understand the synergism 
observed in this study, it is first necessary to parse out the mechanisms of AgSD and 
PROLI/NO action.  The various roles of NO in killing bacteria have been reviewed 
previously.11,14,17,44  As an indiscriminate and short-lived reactant, the target sites available in 
the immediate vicinity of NO play a key role in determining the type of antimicrobial action 
rendered.  Nitric oxide may react directly with the thiols, amines, and transition-metal centers 
of proteins.  It may also react with local small molecules, forming reactive intermediates that 
elicit effects through nitrosative and oxidative interactions with biological molecules.  The 
NO donor used in our study (PROLI/NO) releases NO rapidly upon exposure to aqueous 
solution (t1/2 = 100 s),35,37 where NO and its reactive intermediates likely modify 
biomolecules on the exterior of bacteria, such as membrane-bound proteins and lipids.  
Reaction with O2- forms ONOO-, a strong oxidant that can degrade membranes through lipid 
peroxidation and oxidize nearby proteins, compromising cellular integrity.  Additionally, NO 
is a lipophilic, uncharged, diatomic molecule that readily diffuses across lipid membranes.  
Upon gaining access to the cytoplasm, NO and its congeners may react with numerous 
intracellular proteins and DNA, disrupting crucial cellular processes.  Thus, NO is both an 
extra- and intra-cellular threat to bacteria.  Although the bactericidal effects have been 
demonstrated frequently, little progress has been achieved in identifying specific critical 
targets of NO and its by-products,19,45 likely due to these multi-faceted mechanisms. 
Despite its long-term application for treating chronic and burn wounds topically, AgSD’s 
mechanism(s) of action also remains uncertain.  In aqueous media, AgSD gradually 
dissociates into Ag+ and SD.  Ionic silver reacts directly with thiol-containing amino acids.46  
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Mechanistic studies have shown that treatment with Ag+ affects DNA replication and cellular 
respiration, among other functions.1-6  A member of the sulfonamide family of semisynthetic 
antibacterial agents, SD is a biocide in its own right.  Sulfonamides are structural analogues 
of p-aminobenzoate characterized by their ability to interfere with folate synthesis by 
competitively binding the enzyme dihydropteroate synthase within the cytoplasm of bacteria.  
This process is specifically detrimental to bacteria, as higher organisms obtain this metabolite 
through dietary ingestion.  At physiological pH ~ 7 SD is negatively charged (pKa = 6.48)47 
and less likely to diffuse across biological membranes to access its intracellular target.48  
Despite the potential antimicrobial activity of SD, it is generally believed that Ag+ serves as 
the primary biocide upon AgSD dissociation, at least for topical applications.49  This 
phenomenon was verified in our experiments by showing that treatment with SD alone was 
non-toxic to the 6 strains of bacteria studied. 
As evidenced by the ineffectiveness of SD, the ability of a biocide to access target sites is 
imperative for antimicrobial efficacy.  The outer membrane characteristic of Gram-negative 
species acts as a particularly efficient permeability barrier, conferring intrinsic resistance to 
host defense mechanisms, bile salts and digestive enzymes, and many biocides that are 
effective against other types of bacteria.50  Thus, Gram-negative bacteria are generally more 
tolerant than Gram-positive species of antimicrobial agents.51  Hence, the greater efficacy of 
Ag+ and NO (individually) observed against Gram-negative species may indicate that 
important targets of these biocides reside on the exterior of the bacteria where the rate of 
passive diffusion is less important. When considering the reactivity of Ag+, NO, and NO-
derived by-products, this is not entirely surprising.  Empirical evidence drawn from 
morphological observation supports this hypothesis.  For example Feng et al. used TEM to 
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visualize cell wall damage for E. coli and S. aureus bacteria induced by silver nitrate, with 
the Gram-negative E. coli exhibiting a more pronounced detrimental effect.5  Similarly, 
electron micrographs of AgSD-treated P. aeruginosa and Enterobacter cloacae have 
indicated altered cell wall morphology, while resistant species did not show any changes.52,53  
As previously discussed, NO may function by degrading the lipid membrane itself.  Confocal 
microscopy and atomic force microscopy studies of bacteria after treatment with NO have 
demonstrated increased permeability of the cell wall to dye compounds and deterioration of 
the cell envelope.24,37  Figure 4.2 depicts representative AFM images of E. coli before and 
after treatment with PROLI/NO that both demonstrate degradation of the cell membrane after 
treatment with NO and a positive correlation between dosage and degree of damage. 
4.4.2 Proposed mechanisms for the synergistic action of PROLI/NO and AgSD.  Two 
possible cooperative mechanisms seem plausible based on the cumulative knowledge of Ag+ 
and NO activity, neither of which are mutually exclusive.  Agents that act by disrupting the 
structure of the lipid bilayer or otherwise compromising the cell wall, independent of the 
level of bactericidal activity possessed alone, should in principle work synergistically when 
combined with a second agent whose activity is frustrated by low levels of permeability.  
Such a mechanism was previously demonstrated for the efficacy of streptomycin against E. 
faecalis where the use of cell wall-active agents such as penicillin and vancomycin improved 
the intracellular permeability of the antibiotic.54,55  A similar phenomenon has been 
demonstrated against other Gram-negative and -positive species.34  We hypothesize that such 
synergism may occur if cell wall or membrane damage elicited by Ag+ and/or NO 
significantly increases the permeability of bacteria.  Both of the antimicrobial agents 
evaluated in our study have intracellular activity that would be expected to be enhanced by a  
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Figure 4.2  Representative AFM images of E. coli cells 120 min after treatment with (A) 0 g 
L-1, (B) 1 g L-1, and (C) 2 g L-1 PROLI/NO.  Membrane damage sustained after exposure to 
NO trend with increasing PROLI/NO concentrations. 
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faster rate of entry into the bacteria.  Furthermore, increased permeability of the lipid 
membrane could also allow intracellular access to the anionic SD inhibiting folate synthesis 
in the cytoplasm of bacteria. 
To evaluate this hypothesis, representative Gram-negative (P. aeruginosa) and -positive 
(S. aureus) bacteria were treated with a range of SD concentrations in combination with 
doses of PROLI/NO at one half and one quarter of the respective bactericidal levels.  The 
concentrations of SD tested included the molar bactericidal concentration of AgSD, and 
solutions two- and four-fold greater and less than this concentration.  As SD was found to be 
non-toxic to all the species tested in this study, typical FBC120 indices were unobtainable.  No 
synergistic effect was observed against S. aureus, as the bacterial viability at all 
combinations was indistinguishable from treatment with PROLI/NO alone (Fig. 4.3A-B).  P. 
aeruginosa suffered a slight decrease in viablility at the highest concentration of PROLI/NO 
(4 g L-1) but no obvious synergism was observed at the lower PROLI/NO concentration (2 g 
L-1) (Fig. 4.3C-D).  Thus, although some synergism was observed for P. aeruginosa, the 
effect was lower than what would be expected if this were the primary synergistic 
mechanism.  Even the lowest concentration of SD evaluated (0.875 mg L-1) was almost three-
fold greater than the concentration of AgSD required for synergy against P. aeruginosa (0.31 
mg L-1) with a 4 g L-1 dose of PROLI/NO.  These results indicate that combination treatment 
with NO and SD was not particularly effective against P. aeruginosa or S. aureus over a 2 h 
time frame.  Some enhanced effect may occur at extended periods once endogenous folate 
reserves are depleted and cellular activity decreases due to starvation, but the primary 
mechanism of the acute synergy observed involves both NO and Ag+. 
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Figure 4.3  Bacteria viability over 120 min obtained using efficacy assays to evaluate 
synergy between PROLI/NO and SD.  S. aureus (MSSA) viability was determined using the 
listed range of SD concentrations in combination with (A) 3 g L-1 and (B) 6 g L-1 PROLI/NO.  
Similarly, the viability of P. aeruginosa was evaluated using the SD concentrations listed in 
combination with (C) 2 g L-1 and (D) 4 g L-1 PROLI/NO. 
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Such a mechanism was discussed by Fang,11 who suggested a possible synergistic effect 
in bactericidal efficacy for NO when present during bursts of bacterial respiratory activity.  
Among other bactericidal mechanisms, Ag+ has been implicated in disruption of cellular 
respiration.  Uncoupling of the respiratory chain initially results in stimulated respiration as 
bacteria attempt to regenerate the proton gradient across the membrane.  Dibrov et al. 
demonstrated that the interaction of Ag+ with reconstituted membrane vesicles of Vibrio 
cholerae resulted in the collapse of the proton motive force and dissipation of the proton 
gradient across the bacterial membrane.3  Holt and Bard showed that AgNO3 inhibited the 
respiratory chain by preventing the transport of protons outside of the cell.6  One important 
implication of their study was the probable accumulation of reactive oxygen species such as 
O2- and OH- at the membrane.   The bactericidal efficacy of NO would increase with the 
number of reactive by-products it produces.  For example, if a high concentration of O2- is 
generated upon treatment with Ag+, the resulting increase in ONOO- formation in the 
presence of NO would result in a more rapid rate of oxidative membrane and protein damage.  
Thus, the generation of large quantities of reactive nitrogen and oxygen species following the 
Ag+-induced collapse of the proton gradient across the cell membrane may explain the 
synergistic activity of combined AgSD and PROLI/NO treatment. 
To evaluate this mechanism, both direct and indirect experiments are planned.  The 
production of NO, O2-, and ONOO- may be monitored using metabolite-sensitive fluorescent 
dyes.  Using confocal fluorescent microscopy, co-localization of these reactants with 
bacterial cells may be verified.  Furthermore, the synergistic mechanism may be indirectly 
probed by adjusting the sequence of addition.  If the build-up of O2-results in increased 
ONOO- formation and greater bactericidal efficacy, cellular respiration must still first be 
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inhibited by Ag+.  Hence, synergistic effects observed by varying the order of antimicrobial 
addition may prove useful for verifying the mechanism of action. 
 
4.5 Conclusions 
The combination of AgSD and PROLI/NO is synergistic across a wide range of bacteria 
types, including Gram-positive, Gram-negative, and antibiotic-resistant ‘super bugs’.  
Possible explanations for the synergy include increased access to the cytoplasm due to 
compromised cell envelope and/or an abundance of reactive species resulting from 
uncoupling of cellular respiration.  While it is not clear why the combination of AgSD and 
PROLI/NO is so effective against Gram-positive species, particularly E. faecalis, this trend is 
clear.  The evidence presented herein provides an impetus to further investigate the clinical 
uses of NO in combination with AgSD and other antibiotics.  Possessing the ability to 
efficiently eradicate a wide range of bacterial species, such combinations may be particularly 
useful in topical wound treatment due to the potential for treating polymicrobial and 
antibiotic-resistant infections without fostering selection for resistant species.  Further 
mechanistic studies aimed at elucidating the synergistic action of AgSD and NO would 
provide a strong foundation for developing and improving additional combination therapies. 
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Chapter 5:  
Summary and future research directions 
 
5.1 Summary of research 
The overall goal of my dissertation research has been to contribute to the current 
knowledge of the process of infection and the development and evaluation of novel treatment 
options.  Chapter 2 described the development of a technique for using AFM to measure the 
force required to detach bacteria adhered to a surface using an AFM probe to apply a lateral 
force sufficient to break the adhesive bacteria-surface interactions during a normal contact-
based imaging mode.  Large scan sizes (40 µm2) allowed for concerted acquisition of 
detachment forces for multiple bacteria.  In addition, the total compression of the cantilever 
was determined for each cell detachment event using deflection image analysis.  The 
resulting methodology enabled a more accurate and high-throughput measurement of the 
forces necessary to remove individual cells compared to previous reports.  This technique 
was then applied to measuring Phase II adhesion kinetics (>18 h after initial attachment) of 
two representative pathogens, P. aeruginosa and S. aureus, on a bare substrate.  P. 
aeruginosa reinforced its adhesion to the surface at a rate 7-fold faster than S. aureus, while 
the overall adhesion strength of P. aeruginosa was larger than S. aureus.  Furthermore, it was 
observed that changes in adhesion strength did not proceed uniformly across a population of 
the same species.   
As discussed in Chapter 3, AFM was also employed conduct an analysis of the 
morphological changes undergone by two pathogenic Gram-negative species, E. coli and P. 
aeruginosa, subsequent to NO-treatment.  The Schoenfisch lab has developed and 
characterized numerous NO-releasing scaffolds with bactericidal properties.  Two materials 
embodying different NO-delivery routes were used in this study, namely a polymer coating 
that released NO as a sustained surface flux and a small-molecule donor that delivered its 
payload of NO as a short-duration bolus.  In a qualitative sense, changes in cell morphologies 
subsequent to exposure to NO demonstrated a considerable increase in cellular debris and 
deterioration of the cell wall relative to control cells, while similarities to the morphologies 
exhibited after treatment with the β-lactam amoxicillin also suggested that deterioration of 
the cell envelope is one visible effect of NO-treatment.  From a quantitative standpoint, 
measurements of cell surface roughness were obtained to study the membrane degradation 
induced by NO as a function of time, concentration, and NO-delivery route.  A positive 
correlation was observed between membrane roughness and dose of NO, while NO delivered 
quickly in a bolus induced more damage than a comparable amount of NO delivered via a 
sustained surface flux. 
Chapter 4 introduced modified viability assays that were designed to further explore the 
antimicrobial properties of NO, specifically in combination with a second drug AgSD.  As 
NO is a cell wall-active agent that should increase bacterial permeability, it was hypothesized 
that the combination of NO with a drug whose bactericidal mechanism functions 
intracellularly would elicit a synergistic bactericidal effect.  Previous studies have implicated 
dissociated Ag+ as the primary biocide responsible for antimicrobial action.  As a member of 
the sulfonamide family of synthetic antibiotics (inhibitors of folic acid synthesis), SD has 
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potential intracellular antimicrobial action.  However, it is thought to be inert in topical 
applications as the active, charged species has very low membrane permeability.  Thus, a 
synergistic effect was postulated upon combination of PROLI/NO and AgSD, as membrane 
damage rendered during a burst of NO release should allow SD access to the interior of the 
cell where it can fulfill its antibiotic potential without inhibiting the function of Ag+.   
Standard microdilution and checkerboard viability assays were modified to require 
bactericidal efficacy over a short-duration treatment window (2 h) and conducted to evaluate 
the activity of PROLI/NO and AgSD both individually and in combination. Synergistic 
activity was demonstrated against both Gram-negative and -positive bacteria.  A highly 
synergistic reaction was seen against three of four Gram-positive species tested, including 
vancomycin-resistant E. faecalis.  Two species (P. aeruginosa and MRSA) exhibited FBC120 
values near 0.5 (the standard upper limit for indication of synergy).  Although not technically 
synergistic by traditional standards, it is possible that some synergistic action was observed 
since the duration of exposure used in this study was very short relative to the standard 
synergy determinations for which the FIC and FBC indices were developed. 
 
5.2 Future directions 
5.2.1 Applications of lateral force measurements using AFM to evaluate bacterial 
adhesion.  As presented in Chapter 2, an AFM technique was developed for applying a 
lateral force to detach adhered bacteria.  This method was specifically designed to probe late-
stage (Phase II) adhesion forces, which may be characterized by both specific and non-
specific interactions (see Section 1.1.3 and Fig. 1.2).  While the application described in 
Chapter 2 investigates non-specific interactions developed by S. aureus and P. aeruginosa on 
 151
bare substrates, a second evident research direction would involve the study of specific 
protein-bacteria interactions.  Specific interactions, characterized by molecular recognition 
and (frequently) high-affinity, often confer greater resistance to detachment than non-specific 
interactions.1,2  Some types of specific interactions, termed catch-bonds, are actually 
strengthened in high shear environments.3,4  S. aureus, in particular, has been shown to 
specifically recognize and bind to numerous proteins, including fibrinogen, fibronectin, and 
collagen.2,5-7 Strong interactions with these proteins, present as a conditioning layer on 
implanted material surfaces, are thought to be responsible for the high percentage of S. 
aureus-produced device-related infections.8,9  
Some important variables in experimental design must be optimized.  Surface-bound 
protein may be simply adsorbed or covalently attached to the surface.  Relying on adsorption 
is preferable as it mimics in vivo conditions, while covalent modification may alter protein 
structure, thereby reducing incidence or degree of specific recognition and binding.  
Conversely, it is important to ensure that interactions are breaking between the bacterium and 
the protein, not between the protein and the surface.  In addition, for the investigation of non-
specific interactions, an intermediate drying step proved necessary for achieving measurable 
adhesive forces.10  While this appropriately mimics contamination of a material surface ex 
vivo, it is uncertain how this dehydration step would affect the specific interactions formed 
between bacteria and protein that typically occur in vivo.  Maintaining a hydrated surface 
would be preferable as this would most closely simulate the situation where a bacterium such 
as S. aureus would come into contact with a protein-coated biomaterial. 
Preliminary experiments were undertaken to evaluate the adhesion of S. aureus to 
collagen-coated polyurethane (PU).  Using a polydimethylsiloxane (PDMS) stamp, collagen 
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was patterned onto a PU surface.  Sandwiching the protein between areas of bare substrate 
allows for intra-experiment controls to evaluate both preference and strength of adhesion.  
Protein adsorption was verified, as collagen patterns (e.g., 10 µm stripes) were visualized 
using AFM deflection images, while the stamped region became increasingly hydrophobic on 
the macroscopic scale.  Although sub-monolayer coverage was obtained within the patterned 
regions, S. aureus was seen to preferentially adhere to the protein-patterned regions after 1 h 
incubation.  To more closely mimic an in vivo situation, a closed fluid cell (CFC) that would 
house the cantilever and substrate within a buffered, hydrated environment was coupled to 
the AFM.  A 5-mL suspension of S. aureus was introduced into the CFC for 1 h.  The system 
was flushed with 15 mL of PBS and then imaged in PBS using contact mode.  The overall 
surface coverage of detected cells was low, indicating some unknown variable that either 
discouraged attachment or prevented measurable adhesion forces (i.e., bacteria were 
dislodged at undetectable forces).  Although further optimization is needed, measurement of 
bacterial adhesion to protein-coated materials represents an important line of study for 
understanding both fundamental adhesive interactions and how bacteria adhered to tissue or 
implanted medical devices behave within shearing environments. 
There is no doubt that S. aureus is a troublesome pathogen, expressing not only a variety 
of specific adhesins but also developing resistance mechanisms (e.g., methacillin resistance) 
that are subsequently propagated to future generations and even shared between near 
relatives (e.g., Enterococcus subspecies).11  Our previous study (Chapter 2), however, 
indicated that S. aureus exhibited relatively low adhesion rates to bare xerogel materials 
compared to P. aeruginosa.  This may indicate that materials that resist protein adsorption 
may inhibit the success of S. aureus adhesion events and, subsequently, colonization and 
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infection.  Therefore a second potential application of lateral force measurements would 
entail screening promising materials for their anti-adhesive properties. 
5.2.2 Induction of NO-resistance in bacteria.  Nitric oxide is ubiquitously produced in all 
living systems as a signaling molecule, while in higher organisms it also functions in the 
immune response to infection.  One pressing question that must be asked of any promising 
clinical antibacterial is the potential prevalence for resistance to develop.  Given the 
conserved nature of NO as an endogenous antibacterial (natural selection), it would be 
expected that many pathogenic bacteria would have already evolved resistance mechanisms 
to NO.  To a certain extent this is true, as some bacteria produce low molecular weight 
scavengers and/or up-regulate the expression of certain proteins when exposed to low levels 
of NO.12-16  But, unlike the efflux pumps that efficiently remove large quantities of an 
antibiotic from bacteria, the mechanisms identified for deactivating NO function on a 
molecule-to-molecule basis.  In other words, one protein can effectively neutralize only a 
single molecule of NO.  In fact, this is not surprising as the inherently reactive, broad-
spectrum nature of NO would render most typical means of resistance ineffective.  Thus, 
known NO-resistance mechanisms require a large input of energy, and would likely prove 
insufficient to handle levels of NO-exposure exceeding endogenous concentrations.  
Hence, we hypothesized that the development of resistance to high levels of NO would 
be unlikely.  To probe the upper limit of tolerance, we are attempting to induce bacterial 
resistance to NO.  Cultures of E. coli are treated for 2 h with concentrations of PROLI/NO at 
half the MBC120.  Aliquots of the treated cells are plated on agar, and colonies that grow 
(NO-survivors) are re-cultured in nutrient broth and cycled through another treatment 
process.  Such step-wise selection procedures have proven successful in isolating bacteria 
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resistant to Ag+.17  Through 6 cycles completed thus far, we have been unable to induce a 
tolerance to NO.  While the continuation of negative results only indicates that NO-resistant 
species have not yet emerged, the greater number of consecutive generations exposed to this 
type of treatment can speak for the unlikelihood of resistance developing.  This series of 
experiments is currently under investigation. 
5.2.3 Efficacy of NO against biofilms.  Previous research has inarguably shown the 
effectiveness of NO as an antibacterial agent.18-23  Most of these studies, however, have 
evaluated bacteria either in a planktonic state or within hours after adhesion.  More than half 
of infections, however, are caused by bacteria present in a biofilm community, which are 
notoriously difficult to treat (Section 1.1.4).  In light of NO’s antimicrobial properties, a final 
promising avenue of investigation would be characterization of anti-biofilm activity.  Some 
recent studies have begun to evaluate the efficacy of NO on biofilm communities.  High 
levels of NO delivered from diazeniumdiolate-modified silica nanoparticles were effective at 
killing a range of day-old biofilm-based microbes,23 while low levels of NO delivered from 
S-nitrosothiols have been implicated in initiating dispersal of P. aeruginosa biofilms.24   
To further investigate the anti-biofilm properties of NO, we propose the combined use of 
SEM and confocal fluorescence microscopy.  The excellent resolution afforded by SEM 
allows detailed observation of biofilm morphology before and after NO-treatment.  As 
discussed in Section 1.2.1, fluorescent labelling is a particularly versatile method for 
studying specific qualities of bacteria.  For example, fluorescent tags may be used to 
distinguish between viable and dead bacteria subsequent to treatment.  In addition, the 
simultaneous use of a confocal microscope would allow three-dimensional visualization of 
fluorescence to elucidate properties of the structured community, such as the depth to which 
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NO is capable of rendering bactericidal activity.  To compliment these techniques, metabolic 
activity and biofilm dispersal may be monitored by sampling the liquid matrix containing the 
biofilms.  Certain metabolic intermediates (e.g., ATP) may also be fluorescently labelled and 
quantified, while viable planktonic cells characteristic of dispersal may be detected by 
plating aliquots onto nutrient agar plates and counting the colonies that grow.  Each of these 
techniques could be used to study the pathogen- and dose-dependent effects of NO on 
biofilm viability. 
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5.3 Conclusions 
While it is widely accepted that bacterial adhesion is a time-dependent process, 
surprisingly little is known about how the strength of adhesion changes subsequent to initial 
attachment, primarily as a methodology suitable for acquiring accurate and high-throughput 
force data was lacking.  To address this gap in the infection model, a quantitative technique 
was developed and then applied to obtain the first reported measurements of the kinetics of 
late-stage bacterial adhesion.  Besides contributing to the fundamental understanding of how 
bacterial adhesion changes with time, this technique may be applied to evaluate ultra-low 
adhesion materials that would aid in resisting colonization as well as probing the strength of 
bacteria-protein interactions.  In terms of investigating the problem of infection, the atomic 
force microscope proved an invaluable tool not only for measuring the forces of adhesion, 
but also for visualizing the morphologies of bacteria subsequent to antimicrobial treatment.  
Based on the observed changes in bacterial shape and surface roughness, one cytotoxic 
mechanism of NO proposed was membrane stress.  The presumed increase in cell wall 
permeability would potentially allow improved intracellular access to other antibiotics.  Upon 
combination of NO and AgSD, synergistic activity was indeed noted against a wide range of 
pathogens, including antibiotic-resistant species, highlighting the potential clinical 
application of NO in combination therapy.  Further studies aimed at elucidating the 
synergistic mechanism would aid in identifying additional promising therapeutic 
combinations. 
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Appendix:  
Discussion of assumptions in force measurement 
 
Two assumptions associated with the validity of our technique for force measurement were 
examined: (1) the vectors of the normal force had comparable lateral components over the range 
of cantilever compression values, and (2) all bending of the cantilever occurred in a manner that 
could be modeled, via adaptation of Hooke’s Law (F = k d), to the compression of a spring (i.e., 
along the long axis of the cantilever). 
The force directly measured by the AFM is applied in a direction normal to the bending 
probe (e.g. Fz when scanning a level, flat surface as in Figure 2.1A).  However, when the contact 
point changes from the tip of the probe to the side of the probe, as when imaging a large feature 
such as a bacterium, the applied force (Fapp) felt by the feature is a component of the measured 
force (Eq. 2.1).  The lateral component Flat is the shear force that detaches the cell and is directly 
proportional to the normal force Fapp (Eq. 2.2) (Fig. 2.1B), where θ is the angle between Fapp and 
Flat. 
The actual shape of the cantilever curve as a function of total cantilever compression is 
difficult to predict.  It is thus impossible to accurately determine θ as a function of cantilever 
compression.  By accounting for the geometry of the probe and the cantilever, a model was 
conceived that would yield an approximate value for θ that varies with the degree of cantilever 
deflection.    The lengths of cantilevers used were 115 µm and 196 µm, and the maximum 
displacement from equilibrium achieved during any measurement conducted in these 
experiments did not exceed 800 nm.  As the curvature of the cantilever is slight, it can be 
approximated at a straight line, forming the opposite side of a right triangle (Fig. 2.1B).  The tilt 
of the cantilever from a horizontal position is given by the angle Φ and is equal to 11° for our 
MFP 3D cantilever holder at free air deflection.  As shown in Figure 2B, a direct relationship 
between the angle Φ and the angle θ between the normal force vector and the lateral, or shear, 
component along the x axis can be established under such an approximation for a pyramidal 
probe of known geometry.  The maximum change ∆maxθ between the value of θ at free air 
deflection θmin and that at maximum compression θmax is 0.41° for cantilevers at 115 µm length 
and 0.25° for cantilevers at 186 µm length.  The resulting decrease in Φ corresponds directly 
with the increase in θ.  Using the two equations 
 
Flat, free air    = k d sin (θmin + Φmax) cos (θmin) and 
Flat, maximum compression  = k d sin (θmax + Φmin) cos (θmax) 
 
to determine the variation in vector contribution that could be expected at minimum and 
maximum compression of the cantilevers, we determined that the maximum potential error 
introduced to Flat calculations by assuming the angle θ to be constant is 0.2 % and 0.1 % for 115 
µm and 186 µm cantilevers, respectively.  In all reported Flat, we used a value of 24° for θ, which 
corresponds to the value at free air deflection. 
By adapting Hooke’s Law to calculate forces applied by the probe, this study also assumes 
the cantilever can be modeled by an ideal spring.  In this case the laser position will only move 
along a vertical course on an aligned photodiode in response to lever compression.  However, 
some degree of torsion (i.e., a twisting motion) in the cantilever will naturally occur as a function 
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of normal scanning of a featured surface.  Twist in the cantilever affects the measured deflection 
by causing the position of the laser on the photodiode to move with both a vertical and lateral 
component.  Hooke’s Law converts the measured change in deflection to applied force, and 
deflection measurements are thus read only as the change in output signal resulting from vertical 
displacement of the laser position.  Torsion in the cantilever may become problematic if the 
feedback loop attempts to compensate for the lost z-deflection measured if the twisting is either 
sustained or ill-timed to coincide with piezo adjustment by the feedback loop or if a significant 
lateral force is applied during natural correction of the torque.   
To monitor the level of torsion that occurs during normal scanning, one channel of the AFM 
was directed to monitor the lateral signal (i.e., the displacement of the laser position to the left or 
right of the vertical axis to which it is aligned).  For typical microfabricated triangular cantilevers 
such as the ones used in this study, the detector response for lateral signal change is ~20 – 80 
times smaller than for normal force signals.1  However, we found that under our experimental 
conditions the change in the lateral signal is on the order of nV, at least three orders of 
magnitude smaller than the changes measured in vertical deflection (mV to V), indicating only 
minor degrees of torsion in the cantilever. 
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